Skip to main content
Data in Brief logoLink to Data in Brief
. 2020 Jun 18;31:105878. doi: 10.1016/j.dib.2020.105878

Supporting dataset on the validation and verification of the analytical method for the biomonitoring of 360 toxicologically relevant pollutants in whole blood

Cristian Rial-Berriel a,b,1, Andrea Acosta-Dacal a,1, Fernando González b,c, Natalia Pastor-Tiburón b,c, Manuel Zumbado a,d, Octavio P Luzardo a,b,d,
PMCID: PMC7339027  PMID: 32671142

Abstract

The dataset presented in this article supports “Micro QuEChERS-based method for the simultaneous biomonitoring in whole blood of 360 toxicologically relevant pollutants for wildlife” (Rial-Berriel et al., 2020). The supplementary data are: (1) Detailed validation data of the LC-MS/MS and GC-MS/MS methods for the quantification of 360 chemicals covering bias and precision (intra- and inter-day variability) for retention times, linearity, and limits of quantification. (2) Graphical data of the matrix effects on the quantification of all of the analytes. (3) Individual data of the 51 chemicals detected in real whole blood samples from two raptor species: 36 barn owls (Tyto alba) and 112 common kestrels (Falco tinnunculus).

Keywords: Persistent organic pollutants, Pesticides, Rodenticides, Veterinary pharmaceuticals, Barn owl, Common kestrel, GC-MS/MS, LC-MS/MS


Specifications Table

Subject Environmental Chemistry
Specific subject area Analytical chemistry applied to biological samples to perform biomonitoring of environmental pollutants
Type of data Tables and figures
How data were acquired Ultra-high performance liquid chromatography tandem coupled to triple quadrupole mass spectrometry (LC-MS/MS). Agilent Technologies (Palo Alto, USA) models 1290 (UHPLC) and 6460 (MS/MS).
Gas chromatography tandem coupled to triple quadrupole mass spectrometry (GC-MS/MS). Agilent Technologies (Palo Alto, USA) models 7890B (GC) and 7010 (MS/MS).
Data format Analyzed:
• Extracted and analyzed LC-MS/MS and GC-MS/MS data for the validation studies
• Quantified chromatogram data of pollutants in the blood of barn owls and common kestrels
Raw data:
• All raw data corresponding to the 5 replicates of each concentration tested in the validation experiments presented in Table 1.
• All individual quantitative data obtained after application of the method on 148 common kestrels and 39 barn owls presented in Tables 2–5.
• All raw data used for the elaboration of Fig. 1.
Parameters for data collection The validation data of the developed method included, limit of quantification (as the lowest calibrator that fulfilled de validation criteria), linearity, accuracy (expressed as % bias and precision (intra- and inter-day RSDs)) for each of the 360 analytes.
The matrix effect on the quantification of the analytes is graphically represented as percentages. For clarity the results are expressed as relative percentage.
The quantification data were obtained analyzing a series of 148 blood samples, obtained from a field ecology work in nest boxes of barn owls (Tyto alba, n = 36), and common kestrels (Falco tinnunculus, n = 112).
Description of data collection MassHunter Quantitative Analysis was employed to collect and analyze the chromatographic data delivered by the triple quadrupole mass spectrometers coupled to both UHPLC and GC.
The linearity was assessed by injecting a 12-point calibration curve prepared in the blank matrix and extracted with the developed micro-QuEChERS method.
To test bias and precision, standard solutions of 360 reference standards were employed to spike blank whole blood samples at five concentration levels (0.1, 0.5, 1, 5, and 20 ng/ml) were injected in quintuplicate. The bias and repeatability (intra-day variability) were determined by those quintuplicate analyses of each sample, as these were injected within 24 h. The reproducibility (inter-day variability) was measured on three non-consecutive days within a two-week span.
The matrix effect was assessed by extracting enough amount of blank matrix with the developed method and fortifying these extracts with three levels of the mixture of 360 chemicals (0.2, 2, and 10 ng/ml), and quantified against a calibration curve prepared in the solvent (1% FA-acetonitrile).
Regarding the quantitative data, the real samples were prepared with the developed methodology and analyzed by UHPLC and GC.
Data source location Institution: Toxicology Unit, Research Institute of Biomedical and Health Sciences (IUIBS), University of Las Palmas de Gran Canaria
City/Town/Region: Las Palmas de Gran Canaria
Country: Spain
Data accessibility With the article. Raw data are provided
Related research article Rial-Berriel, C., Acosta-Dacal, A., Zumbado, M., Luzardo, O.P. Micro QuEChERS-based methodology for the simultaneous biomonitoring in whole blood of 360 toxicologically relevant pollutants for wildlife. Science of the Total Environment 736 (2020) 13944

Value of the data

  • An easy way to consult the validation data of the methodological development detailed in the main article is provided.

  • Additionally, the validation data might serve as a reference to other researchers developing methods in complex biological matrices.

  • The detail of the matrix effect on each of the 360 compounds analyzed may allow other researchers to decide whether they need to prepare their calibration lines in matrix or in solvent.

  • Data on numerous environmental pollutants are presented for the first time for two apex predators: barn owl (Tyto alba) and kestrel (Falco tinnunculus).

  • The biomonitoring data presented can be used by other researchers in ecotoxicology for comparison purposes, and for meta-analyses of chemical contamination in birds of prey.

Data description

Table 1 shows the major validation parameters of each of the 360 chemicals optimized in this methodology. Validation criteria fulfilled those established in the SANTE guidelines [1]. Given the particularities of the matrix - whole blood - the guidelines of the SWGTOX were also considered, especially concerning the preparation of the matrix-matched calibration curve [2]. The data reported in this table complement those included in Table 1 of the article by Rial-Berriel et al. [3], where the parameters of identity and selectivity of each compound are shown. Now, in this table, the data of linearity (as a working range), the LOQ (set as the lowest point of the calibration curve that complied identity, bias and precision criteria), repeatability (as intraday RSD), and reproducibility (as interday RSD) are shown for each of the chemicals. The bias and precision (repeatability and reproducibility) data are presented for five fortification levels (0.1, 0.5, 1, 5, and 20 ng/ml). Raw data of the five replicates for each concentration are provided in the supplementary file 1.

Table 1.

Results of validation process: LOQ, linearity, bias and precision (intraday and interday).

0.1ng/ml
0.5ng/ml
1ng/ml
5ng/ml
20ng/ml
Precision (RSD. %)
Precision (RSD. %)
Precision (RSD. %)
Precision (RSD. %)
Precision (RSD. %)
Compound LOQ Linearity Bias (%) Intraday Interday Rec. (%) Intraday Interday Rec. (%) Intraday Interday Rec. (%) Intraday Interday Rec. (%) Intraday Interday
1 2-Phenylphenol 0.20 0.9946 N/A N/A N/A 110.10 8,99 11.18 100.03 8,25 6.86 86.09 6,67 8.32 100.98 13,03 1.62
2 4.4′-Dichlorobenzophenone (metabolite of dicofol) 0.80 0.9905 N/A N/A N/A N/A N/A N/A 100.35 8,41 12.21 101.69 6,90 17.71 96.39 13,85 1.72
3 Abamectine 4.00 0.9784 N/A N/A N/A N/A N/A N/A N/A N/A N/A 107.86 6,77 14.19 102.58 15,24 4.37
4 Acenaphthene 0.20 0.9889 N/A N/A N/A 83.21 17,09 8.12 124.25 9,64 7.02 94.92 6,78 10.11 96.71 7,51 8.70
5 Acenaphtylene 0.20 0.9792 N/A N/A N/A 108.10 14,25 15.63 99.81 10,39 5.64 94.84 15,98 10.11 102.65 7,26 9.23
6 Acephate 2.00 0.9879 N/A N/A N/A N/A N/A N/A N/A N/A N/A 119.99 13,67 0.16 103.25 7,44 12.14
7 Acetaminophen (paracetamol) 1.20 0.9548 N/A N/A N/A N/A N/A N/A 126.11 7,73 13.96 79.54 17,10 13.04 105.72 14,92 29.30
8 Acetamiprid 0.40 0.9967 N/A N/A N/A 113.51 14,76 3.73 97.67 11,75 2.41 104.22 17,94 4.72 95.95 7,89 1.24
9 Acrinathrin 1.20 0.9943 N/A N/A N/A N/A N/A N/A 109.46 9,36 10.87 93.81 6,62 5.87 99.70 16,60 9.75
10 Albendazole 0.10 0.9952 121.06 10,61 8.38 96.22 9,08 10.63 99.00 10,54 1.33 108.29 17,77 3.44 96.38 14,56 0.81
11 Aldicarb 0.10 0.9956 118.27 18,28 14.53 98.52 10,06 4.99 92.82 8,85 1.70 102.55 6,62 5.28 95.35 13,66 3.09
12 Aldicarb-sulfone 0.40 0.9966 N/A N/A N/A 118.79 12,30 5.58 93.35 10,83 7.71 99.82 6,62 4.56 96.53 7,31 1.87
13 Aldicarb-sulfoxide 1.60 0.9936 N/A N/A N/A N/A N/A N/A N/A N/A N/A 100.26 6,62 1.11 94.55 7,50 0.14
14 Aldrin 0.40 0.9951 N/A N/A N/A 95.34 15,89 4.08 97.07 13,35 9.52 95.19 6,86 0.34 97.66 7,25 1.76
15 Anthracene 0.80 0.9579 N/A N/A N/A N/A N/A N/A 114.90 7,72 6.49 92.78 14,13 9.89 95.94 14,59 8.63
16 Atrazine 0.10 0.9960 107.95 8,69 1.74 97.69 16,36 17.22 93.12 13,51 3.34 103.37 15,25 5.44 95.62 8,06 0.71
17 Azinphos-methyl 0.20 0.9961 N/A N/A N/A 108.57 8,99 1.85 95.64 10,75 3.62 107.13 15,31 3.49 94.57 13,68 0.15
18 Azoxystrobin 0.10 0.9972 103.13 15,68 1.38 96.51 8,98 17.06 97.09 10,29 4.55 104.23 17,56 7.15 97.49 15,71 4.20
19 BDE-28 0.20 0.9932 N/A N/A N/A 103.43 8,92 12.34 101.66 8,32 5.74 90.52 6,73 9.65 90.60 17,40 8.15
20 BDE-47 0.20 0.9924 N/A N/A N/A 96.70 15,12 7.67 100.78 11,76 5.69 91.21 17,86 9.72 94.25 8,12 8.48
21 BDE-85 0.10 0.9954 129.76 10,28 5.15 91.22 13,95 11.00 101.98 12,44 5.76 86.00 7,35 9.16 99.65 7,39 8.96
22 BDE-99 0.10 0.9934 91.23 5,37 4.22 105.76 14,85 14.54 103.28 13,00 5.83 94.33 6,64 10.05 94.77 7,85 8.52
23 BDE-100 0.10 0.9873 109.21 8,67 7.98 89.95 10,40 11.20 101.34 10,20 5.72 92.07 6,78 9.81 85.36 16,69 7.68
24 BDE-153 0.20 0.9951 N/A N/A N/A 86.36 13,46 10.95 102.38 10,65 5.78 98.11 6,62 10.45 95.42 7,26 8.58
25 BDE-154 0.10 0.9954 111.23 7,50 8.20 109.41 9,31 11.22 101.80 8,92 5.75 94.84 15,34 10.11 91.95 15,43 8.27
26 BDE-183 0.20 0.9815 N/A N/A N/A 98.77 10,04 7.64 103.39 8,47 5.84 98.97 14,04 10.55 103.42 15,38 9.30
27 Benalaxyl 0.10 0.9978 97.07 10,61 4.88 91.75 10,74 5.04 96.40 9,17 0.54 102.02 17,93 2.34 98.23 14,16 2.16
28 Bendiocarb 0.10 0.9961 106.43 17,38 11.19 98.54 16,51 11.11 88.59 11,92 0.30 101.12 17,69 7.81 95.22 7,38 1.33
29 Bendiocarb metabolite (2. 2‐dimethylbenzo‐1. 3‐dioxol‐4‐ol) 1.20 0.9968 N/A N/A N/A N/A N/A N/A 100.90 12,67 0.91 82.48 6,69 8.04 99.56 13,52 3.43
30 Benfuracarb 0.10 0.9950 86.06 8,05 10.19 103.65 14,71 15.73 99.20 13,07 2.80 106.49 13,63 4.43 95.72 14,04 5.01
31 Benzo[a]anthracene 0.80 0.9805 N/A N/A N/A N/A N/A N/A 111.54 7,78 6.30 94.91 6,69 10.11 89.36 9,08 8.04
32 Benzo[a]pyrene 0.10 0.9948 124.45 14,20 9.32 95.76 14,39 6.53 112.23 10,04 6.34 95.02 6,67 10.13 101.13 12,65 9.09
33 Benzo[b]fluoranthene 0.80 0.9766 N/A N/A N/A N/A N/A N/A 105.05 8,54 5.93 92.65 6,62 9.87 98.55 10,27 8.86
34 Benzo[ghi]perylene 0.40 0.9912 N/A N/A N/A 119.14 9,12 7.22 111.18 12,61 6.28 99.29 6,67 10.58 103.47 9,06 9.30
35 Benzo[k]fluoranthene 0.40 0.9323 N/A N/A N/A 95.12 9,17 9.12 95.35 15,14 5.39 100.05 16,54 10.66 94.17 10,62 8.47
36 Bifenthrin 0.20 0.9952 N/A N/A N/A 98.48 13,53 12.82 102.14 10,00 1.84 89.51 18,10 3.56 95.27 13,67 5.57
37 Bitertanol 0.40 0.9938 N/A N/A N/A 105.62 14,27 15.92 105.68 9,81 13.20 102.68 10,19 5.54 96.23 14,00 7.53
38 Boscalid (formerly nicobifen) 0.10 0.9974 112.80 9,55 7.39 101.63 14,86 4.10 97.54 10,08 6.17 84.80 10,06 7.47 100.58 12,54 5.73
39 Brodifacoum 0.80 0.9806 N/A N/A N/A N/A N/A N/A 92.73 13,12 5.11 96.45 15,56 15.43 100.49 9,93 12.33
40 Bromadiolone 0.40 0.9864 N/A N/A N/A 116.06 10,17 18.62 89.90 9,56 5.46 112.93 9,46 3.98 100.80 16,46 0.11
41 Bromopropylate 0.20 0.9887 N/A N/A N/A 99.38 14,28 11.80 102.94 12,91 14.65 88.10 13,47 2.10 98.29 9,89 17.90
42 Bromuconazole (two isomers) 0.20 0.9821 N/A N/A N/A 97.91 12,92 8.33 98.52 13,61 11.16 87.58 14,54 19.50 99.45 9,70 9.08
43 Bupirimate 0.20 0.9940 N/A N/A N/A 97.15 13,95 10.65 97.41 12,47 1.67 88.40 9,36 2.98 97.21 10,00 5.20
44 Buprofezin 0.10 0.9930 111.89 12,12 7.55 93.70 10,78 4.48 91.32 8,97 3.26 96.80 11,53 3.61 97.21 15,68 7.98
45 Cadusafos (ebufos) 0.10 0.9956 86.62 9,70 9.96 94.38 9,34 11.50 103.53 9,81 5.16 105.85 13,64 4.40 95.85 15,07 2.52
46 Carbaryl 0.10 0.9978 106.07 9,25 5.31 94.48 9,87 3.35 98.38 10,04 9.69 105.00 13,67 4.09 96.64 14,97 3.48
47 Carbendazim (azole) 0.40 0.9965 N/A N/A N/A 118.80 13,28 3.68 94.83 13,87 3.95 101.66 13,34 4.74 97.47 9,11 2.27
48 Carbofuran 0.10 0.9959 118.09 12,71 9.84 93.02 11,68 15.57 90.26 9,61 3.87 98.83 12,60 9.04 96.21 14,66 4.67
49 Carbofuran-3-hydroxy 0.40 0.9963 N/A N/A N/A 117.69 12,90 6.37 96.99 13,89 4.38 103.10 13,92 4.90 95.70 9,44 2.86
50 Carbosulfan 0.40 0.9781 N/A N/A N/A 132.53 12,51 5.32 84.83 13,15 18.63 110.47 9,64 9.70 105.49 9,25 3.40
51 Cefuroxima axetil (two isomers) 0.80 0.9902 N/A N/A N/A N/A N/A N/A 105.25 14,44 3.61 100.04 10,23 5.53 104.99 8,89 2.88
52 Chloramphenicol 2.00 0.9814 N/A N/A N/A N/A N/A N/A N/A N/A N/A 120.55 9,33 11.01 102.82 12,43 9.86
53 Chlorantraniliprole 0.20 0.9952 N/A N/A N/A 107.14 9,74 13.70 91.93 9,32 10.91 104.44 9,61 6.25 95.70 13,94 4.00
54 Chlorfenapyr 1.20 0.9936 N/A N/A N/A N/A N/A N/A 97.07 8,89 12.36 85.57 13,88 11.55 106.01 14,26 1.61
55 Chlorfenvinphos 0.20 0.9969 N/A N/A N/A 96.71 14,12 11.93 100.05 14,95 5.73 102.06 9,37 0.48 96.97 9,73 0.29
56 Chlorobenzilate 0.40 0.9909 N/A N/A N/A 88.96 9,99 9.32 105.63 8,87 5.97 87.66 15,64 9.34 89.59 14,82 8.06
57 Chlorophacinone 0.80 0.9874 N/A N/A N/A N/A N/A N/A 96.82 12,73 1.94 103.81 13,52 2.08 100.62 9,72 4.45
58 Chlorpropham 0.20 0.9949 N/A N/A N/A 110.12 13,64 10.89 101.16 13,17 9.22 85.27 16,60 9.82 97.24 10,40 9.23
59 Chlorpyrifos 0.80 0.9915 N/A N/A N/A N/A N/A N/A 100.64 14,14 10.32 91.52 15,69 7.57 100.79 10,24 7.46
60 Chlorpyrifos methyl 0.40 0.9951 N/A N/A N/A 103.73 9,45 7.79 104.81 9,61 13.90 88.99 10,69 10.67 99.45 13,30 4.76
61 Chlorthal dimethyl 0.20 0.9874 N/A N/A N/A 91.40 11,74 4.48 107.91 8,89 7.07 90.69 9,27 3.38 96.20 14,69 7.87
62 Chrysene 0.80 0.9789 N/A N/A N/A N/A N/A N/A 109.29 9,22 6.17 93.19 9,29 9.93 94.31 13,57 8.48
63 Clindamycin 0.40 0.9970 N/A N/A N/A 116.37 11,77 4.52 96.24 12,64 9.31 104.48 10,53 6.42 97.59 9,89 1.83
64 Clofentezine 0.40 0.9944 N/A N/A N/A 101.79 9,49 2.24 96.83 9,70 1.32 107.77 13,16 5.27 98.86 14,77 0.82
65 Clothianidin 1.20 0.9941 N/A N/A N/A N/A N/A N/A 89.69 13,57 2.55 100.83 9,18 9.29 93.83 9,88 2.69
66 Cloxacillin 1.60 0.9803 N/A N/A N/A N/A N/A N/A N/A N/A N/A 110.09 14,70 3.00 101.78 9,10 3.38
67 Cortiscosterone 21 acetate 0.80 0.9948 N/A N/A N/A N/A N/A N/A 116.41 14,25 25.41 105.76 12,62 1.63 97.81 9,06 4.02
68 Coumachlor 0.20 0.9948 N/A N/A N/A 95.39 9,51 2.10 101.51 9,31 2.76 109.44 14,42 6.63 99.44 16,00 6.43
69 Coumaphos 0.10 0.9977 116.47 12,99 9.03 87.29 10,10 2.13 93.40 8,98 5.88 102.10 12,07 4.65 98.22 13,49 5.08
70 Coumatetralyl 0.40 0.9791 N/A N/A N/A 104.44 9,23 14.38 104.06 9,03 13.27 91.59 9,96 1.15 98.21 14,37 11.04
71 Cyazofamid 0.80 0.9973 N/A N/A N/A N/A N/A N/A 106.76 12,52 2.68 103.61 10,04 6.11 98.92 9,10 1.86
72 Cyflufenamid 0.20 0.9936 N/A N/A N/A 85.26 11,55 2.59 112.30 9,20 13.66 110.04 9,40 2.12 96.14 14,03 7.41
73 Cyfluthrin (sum of four isomers) 1.20 0.9923 N/A N/A N/A N/A N/A N/A 102.22 15,22 2.03 89.47 10,43 0.08 100.93 9,55 0.81
74 Cyhalothrin (lambda isomer) 2.00 0.9938 N/A N/A N/A N/A N/A N/A N/A N/A N/A 95.52 15,51 10.00 100.53 9,65 1.89
75 Cymoxanil 0.40 0.9975 N/A N/A N/A 114.66 12,65 10.00 96.84 14,55 1.40 101.03 9,71 5.35 96.68 10,08 1.83
76 Cypermethrin (sum of four isomers) 4.00 0.9886 N/A N/A N/A N/A N/A N/A N/A N/A N/A 94.85 13,60 7.83 102.11 14,45 7.39
77 Cyproconazole (two isomers) 0.40 0.9952 N/A N/A N/A 102.85 10,03 18.32 98.08 9,04 4.73 104.80 13,46 5.60 96.12 14,27 2.98
78 Cyprodinil 0.20 0.9945 N/A N/A N/A 109.65 9,34 10.35 95.04 10,01 19.09 103.39 14,24 5.60 95.75 12,78 3.91
79 Cyromazine 2.00 0.9904 N/A N/A N/A N/A N/A N/A N/A N/A N/A 97.88 15,22 0.44 101.73 10,16 2.26
80 Danofloxacin 1.20 0.9698 N/A N/A N/A N/A N/A N/A 87.87 15,46 4.73 88.06 9,23 1.32 95.42 16,22 21.72
81 Dazomet 1.60 0.9954 N/A N/A N/A N/A N/A N/A N/A N/A N/A 107.37 10,51 9.72 100.18 9,74 4.16
82 Deltamethrin 0.80 0.9927 N/A N/A N/A N/A N/A N/A 104.72 7,30 11.36 118.20 12,06 2.60 98.42 8,92 1.75
83 Demeton-S-methyl 0.10 0.9966 113.64 12,45 4.39 98.56 13,75 7.34 91.34 8,63 1.66 100.20 14,19 7.48 95.83 12,90 0.52
84 Demeton-S-methyl-sulfone (Dioxydemeton) 0.40 0.9962 N/A N/A N/A 116.45 10,04 12.58 98.84 15,84 1.65 101.43 12,71 5.48 97.04 9,37 0.23
85 Dexamethasone 0.40 0.9920 N/A N/A N/A 129.03 9,03 9.22 100.41 12,98 4.52 102.29 13,81 11.14 94.51 10,33 0.39
86 Diazinon 0.40 0.9923 N/A N/A N/A 106.32 10,31 1.65 110.27 15,60 13.64 90.53 9,96 8.70 97.56 10,05 3.30
87 Dibenzo[a.h]anthracene 0.40 0.9884 N/A N/A N/A 122.87 13,55 14.78 106.79 7,27 6.03 95.70 13,68 10.20 100.26 14,21 9.02
88 Dichlorodiphenyldichloroethane (p.p’ DDD) 0.10 0.9783 93.23 6,40 7.21 95.01 10,77 9.24 115.50 12,04 6.52 88.01 14,59 9.38 86.76 10,58 7.80
89 Dichlorodiphenyldichloroethylene (p.p’ DDE) 0.10 0.9848 94.34 8,74 5.45 95.01 15,21 7.23 115.50 7,37 6.52 88.01 13,38 9.38 86.76 15,66 7.80
90 Dichlorodiphenyltrichloroethane (p.p’ DDT) 1.20 0.9740 N/A N/A N/A N/A N/A N/A 124.05 7,26 4.15 82.09 11,36 19.34 97.14 12,26 17.84
91 Diclofenac 0.80 0.9677 N/A N/A N/A N/A N/A N/A 79.69 9,75 18.79 104.25 15,50 6.86 104.76 14,33 0.55
92 Dicloran 0.10 0.9836 123.22 9,55 8.22 108.31 9,22 11.23 114.09 14,60 6.44 107.57 9,01 11.46 99.19 9,49 8.92
93 Dicloxacillin 1.20 0.9832 N/A N/A N/A N/A N/A N/A 118.47 13,71 25.92 107.63 9,22 2.05 94.46 11,45 8.19
94 Dieldrin 1.20 0.9916 N/A N/A N/A N/A N/A N/A 90.79 16,01 2.75 93.04 10,08 18.65 102.23 10,10 6.68
95 Diethathyl ethyl 0.20 0.9949 N/A N/A N/A 101.03 13,95 15.93 97.12 8,14 6.24 109.86 9,80 1.29 97.92 13,74 5.33
96 Diethofencarb 0.10 0.9974 109.28 9,41 9.22 99.69 10,24 14.33 90.50 16,03 5.04 103.94 14,12 11.39 97.29 9,31 3.12
97 Difenacoum 0.20 0.9821 N/A N/A N/A 106.25 12,62 0.67 97.13 7,96 1.76 89.59 15,15 10.58 101.79 12,53 13.24
98 Difenoconazole 0.40 0.9962 N/A N/A N/A 110.55 14,29 2.18 97.28 7,66 6.95 103.07 15,99 5.52 98.83 15,16 3.65
99 Difethialone 0.80 0.9710 N/A N/A N/A N/A N/A N/A 95.73 7,39 17.88 91.34 16,61 15.31 102.52 12,84 22.89
100 Difloxacin 0.80 0.9702 N/A N/A N/A N/A N/A N/A 74.73 16,49 11.56 95.04 9,89 3.47 97.27 10,00 24.41
101 Diflubenzuron 1.20 0.9909 N/A N/A N/A N/A N/A N/A 82.74 13,96 13.97 104.38 14,08 2.84 97.93 9,13 8.15
102 Diflufenican 0.10 0.9943 104.94 10,18 11.58 95.70 10,05 10.45 85.39 14,12 4.30 110.99 9,10 5.78 99.81 9,32 0.67
103 Dimethenamid-P (and its R-isomer) 0.10 0.9963 127.37 6,66 4.97 101.55 13,43 3.07 91.45 8,20 11.35 91.32 9,36 16.95 96.98 14,60 0.53
104 Dimethoate 0.40 0.9967 N/A N/A N/A 122.10 9,22 0.83 98.13 15,13 4.07 102.92 10,29 6.04 97.11 11,18 0.20
105 Dimethomorph (two isomers) 0.40 0.9966 N/A N/A N/A 117.73 13,92 4.31 97.14 8,28 2.29 101.37 9,10 8.66 97.41 15,53 2.53
106 Dimethylphenylsulfamide (DMSA. metabolite of dichlofluanid) 0.80 0.9971 N/A N/A N/A N/A N/A N/A 99.37 8,54 5.30 97.54 13,42 8.62 98.06 12,18 1.27
107 Diniconazole-M 0.20 0.9972 N/A N/A N/A 110.11 12,82 18.86 86.32 9,11 8.30 103.99 14,19 10.86 98.08 14,05 0.98
108 Dinocap 0.80 0.9847 N/A N/A N/A N/A N/A N/A 90.93 15,41 5.14 102.73 15,20 10.95 95.70 9,66 8.61
109 Diphacinone 1.20 0.9892 N/A N/A N/A N/A N/A N/A 115.88 13,56 4.43 105.36 16,11 8.05 98.59 9,73 5.59
110 Diphenylamine 0.20 0.9938 N/A N/A N/A 104.56 10,04 10.33 100.70 16,33 1.21 81.45 9,71 11.19 103.06 9,82 2.82
111 Dodine 0.40 0.9953 N/A N/A N/A 98.40 15,62 11.83 102.50 8,23 1.46 101.49 12,47 2.92 95.74 15,22 2.74
112 Endosulfan alfa 0.80 0.9931 N/A N/A N/A N/A N/A N/A 101.76 12,52 13.79 86.34 9,89 13.22 100.60 9,22 2.10
113 Endosulfan beta 0.80 0.9859 N/A N/A N/A N/A N/A N/A 116.18 8,01 17.11 94.87 8,97 15.61 102.32 12,87 8.66
114 Endosulfan sulfate 0.80 0.9884 N/A N/A N/A N/A N/A N/A 111.36 7,97 4.46 99.14 10,28 12.76 101.10 13,93 4.21
115 Endrin 1.60 0.9961 N/A N/A N/A N/A N/A N/A N/A N/A N/A 105.62 8,92 11.25 83.94 14,41 7.55
116 Enrofloxacin 1.20 0.9569 N/A N/A N/A N/A N/A N/A 90.24 14,45 1.61 79.66 13,76 16.02 92.99 11,50 34.07
117 EPN 0.80 0.9873 N/A N/A N/A N/A N/A N/A 100.07 16,63 3.78 94.94 15,70 17.91 98.99 9,19 2.59
118 Epoxiconazole 0.20 0.9966 N/A N/A N/A 109.95 10,50 2.71 87.76 17,90 15.32 99.14 13,04 5.31 97.64 9,13 1.60
119 Eprinomectin 0.20 0.9878 N/A N/A N/A 121.34 13,63 9.72 99.91 7,56 12.53 112.05 8,92 1.98 106.09 11,98 0.52
120 Eritromicin 0.20 0.9967 N/A N/A N/A 105.88 10,86 6.29 96.88 16,44 3.65 103.97 9,77 6.11 96.79 10,70 3.68
121 Esfenvalerate 2.00 0.9936 N/A N/A N/A N/A N/A N/A N/A N/A N/A 96.38 10,37 3.14 96.89 13,24 5.12
122 Ethion (diethion) 0.10 0.9958 103.66 7,72 0.78 89.88 15,17 3.73 95.28 7,88 3.77 108.49 8,87 4.58 100.49 15,28 4.16
123 Ethirimol 0.40 0.9964 N/A N/A N/A 122.23 12,67 1.90 96.57 12,01 0.27 104.84 12,91 3.65 98.37 13,21 4.56
124 Ethofumesate 0.80 0.9846 N/A N/A N/A N/A N/A N/A 91.55 10,20 4.97 82.64 18,27 14.03 98.52 10,25 11.95
125 Ethoprophos 0.20 0.9953 N/A N/A N/A 96.56 9,60 16.85 96.29 10,50 4.92 102.00 14,06 7.17 95.03 11,29 2.62
126 Etofenprox 0.80 0.9963 N/A N/A N/A N/A N/A N/A 98.75 10,23 4.30 93.90 15,00 7.98 100.65 9,10 5.37
127 Etoxazole 0.10 0.9972 106.66 6,86 18.17 87.77 16,23 9.12 91.35 9,95 7.34 103.72 9,01 3.18 100.75 13,94 4.65
128 Famoxadone 1.20 0.9942 N/A N/A N/A N/A N/A N/A 109.69 9,40 14.42 101.73 12,93 9.40 98.87 10,38 3.93
129 Fenamidone 0.10 0.9976 100.84 9,44 2.17 102.38 12,60 9.41 99.89 9,41 9.34 105.57 9,85 4.55 97.86 13,99 2.26
130 Fenamiphos 0.10 0.9976 92.87 15,36 1.25 94.57 14,70 9.17 99.28 8,99 1.65 107.18 9,85 5.85 95.32 13,62 3.93
131 Fenamiphos sulfone 0.20 0.9971 N/A N/A N/A 109.57 13,30 6.60 90.42 10,49 0.60 103.95 8,98 7.13 96.59 15,51 1.85
132 Fenamiphos sulfoxide 0.40 0.9963 N/A N/A N/A 120.76 9,74 4.40 96.93 9,25 3.43 99.10 9,42 7.16 97.96 10,91 0.25
133 Fenarimol 0.20 0.9960 N/A N/A N/A 107.08 10,55 8.23 100.38 7,97 1.42 91.15 14,84 3.62 98.31 9,95 0.95
134 Fenazaquin 0.80 0.9967 N/A N/A N/A N/A N/A N/A 103.00 7,70 4.49 107.95 15,93 4.82 99.17 17,83 1.81
135 Fenbendazole 0.10 0.9959 117.39 10,22 0.85 96.83 15,21 7.43 92.86 10,50 12.54 111.90 15,15 3.55 96.47 6,84 0.78
136 Fenbuconazole 0.40 0.9943 N/A N/A N/A 106.97 10,09 11.96 97.78 8,02 4.11 82.91 16,31 2.82 96.67 17,54 4.23
137 Fenbutatin oxide 0.80 0.9705 N/A N/A N/A N/A N/A N/A 101.12 10,91 2.09 101.73 10,08 2.23 109.08 6,62 3.83
138 Fenhexamid 1.60 0.9952 N/A N/A N/A N/A N/A N/A N/A N/A N/A 94.50 12,93 5.93 100.97 6,91 1.63
139 Fenitrothion 0.20 0.9946 N/A N/A N/A 96.00 13,47 1.84 104.50 10,63 18.04 89.65 10,40 10.92 98.77 6,63 0.21
140 Fenoxycarb 0.10 0.9950 106.29 15,35 14.48 89.97 9,71 10.85 88.98 8,95 0.61 108.29 14,13 1.92 101.10 17,34 1.20
141 Fenpropathrin 0.40 0.9932 N/A N/A N/A 96.77 9,48 4.11 108.60 7,36 7.89 114.09 15,57 4.22 98.64 14,32 2.46
142 Fenpropidin 0.10 0.9971 107.57 7,02 6.44 95.01 9,25 14.96 95.57 8,20 6.27 104.76 14,60 3.69 98.78 16,42 2.87
143 Fenpropimorph 0.10 0.9967 112.10 6,69 5.06 91.37 15,36 6.27 98.02 11,73 3.30 105.01 7,29 4.62 98.31 7,08 2.04
144 Fenpyroximate 0.40 0.9972 N/A N/A N/A 108.10 9,24 11.74 98.03 9,60 3.42 110.63 7,30 7.96 99.89 14,81 3.51
145 Fenthion 0.10 0.9907 101.39 8,20 9.98 98.48 14,20 6.59 100.84 10,07 1.09 93.69 7,24 3.06 97.74 6,90 2.60
146 Fenthion oxon 0.10 0.9981 102.81 9,49 11.00 93.65 12,81 5.77 95.62 9,66 2.50 103.73 7,29 4.97 97.83 6,63 1.80
147 Fenthion oxon sulfone 0.80 0.9978 N/A N/A N/A N/A N/A N/A 99.68 9,78 2.02 101.55 16,22 6.88 98.19 6,93 2.88
148 Fenthion oxon sulfoxide 0.20 0.9977 N/A N/A N/A 119.70 9,46 1.24 99.13 9,09 5.16 101.41 7,40 5.89 97.91 18,80 0.84
149 Fenthion sulfone 0.80 0.9980 N/A N/A N/A N/A N/A N/A 102.66 8,33 0.50 101.78 13,19 9.01 98.32 17,66 2.07
150 Fenthion sulfoxide 0.40 0.9991 N/A N/A N/A 106.77 10,32 6.95 103.30 9,24 8.77 103.57 16,11 4.88 95.47 15,28 1.90
151 Fenvalerate 2.00 0.9939 N/A N/A N/A N/A N/A N/A N/A N/A N/A 91.05 15,63 10.82 98.09 6,62 1.48
152 Fipronil 0.20 0.9946 N/A N/A N/A 104.05 9,16 2.31 90.35 10,22 2.29 101.81 13,15 4.10 100.66 15,46 0.15
153 Fipronil sulfide 0.80 0.9391 N/A N/A N/A N/A N/A N/A 98.90 11,00 8.97 84.35 7,92 13.73 95.07 7,23 27.31
154 Flocoumafen 0.20 0.9737 N/A N/A N/A 115.03 13,55 2.97 97.42 10,83 10.78 81.77 8,58 6.71 99.46 6,62 19.13
155 Fluazinam 0.20 0.9942 N/A N/A N/A 109.04 13,34 9.01 95.48 10,76 4.20 101.92 7,31 1.50 96.92 6,62 2.29
156 Flubendiamide 2.00 0.9829 N/A N/A N/A N/A N/A N/A N/A N/A N/A 91.98 8,33 10.12 95.45 17,55 9.10
157 Flucythrinate (two isomers) 0.80 0.9951 N/A N/A N/A N/A N/A N/A 100.00 9,93 2.37 93.42 16,52 4.71 99.66 14,19 4.20
158 Fludioxonil 0.20 0.9924 N/A N/A N/A 99.12 9,56 6.85 96.89 9,31 6.19 88.02 7,25 3.14 98.96 17,89 9.67
159 Flufenoxuron 0.10 0.9942 107.97 6,05 14.68 88.19 14,34 10.25 88.31 12,00 4.19 112.03 7,62 4.34 102.01 6,75 2.92
160 Flumequine 0.10 0.9876 106.13 8,91 23.04 100.69 11,01 10.95 91.44 8,68 9.51 96.97 9,32 10.04 91.89 15,61 17.35
161 Flunixin 0.20 0.9949 N/A N/A N/A 96.90 14,66 4.63 91.59 9,37 1.62 110.14 7,43 2.78 98.17 6,63 0.65
162 Fluopyram 0.20 0.9958 N/A N/A N/A 110.51 12,65 3.31 97.01 11,93 0.48 94.66 9,95 8.92 96.17 6,77 6.46
163 Fluoranthene 0.20 0.9887 N/A N/A N/A 109.74 13,17 6.76 104.20 11,02 5.89 94.00 7,25 10.02 85.54 7,48 7.69
164 Fluorene 0.20 0.9836 N/A N/A N/A 148.49 9,00 13.22 111.31 8,80 6.29 92.49 16,86 9.86 93.39 17,74 8.40
165 Fluquinconazole 0.20 0.9869 N/A N/A N/A 103.74 10,15 12.58 96.88 8,10 4.65 88.44 17,22 1.18 96.68 17,03 13.29
166 Flusilazole 0.20 0.9946 N/A N/A N/A 94.54 9,43 10.00 89.82 10,64 0.48 114.38 15,47 2.02 98.57 14,14 2.32
167 Flutolanil 0.10 0.9975 106.84 7,89 11.91 89.48 13,65 6.56 100.18 11,64 5.67 106.33 16,01 3.74 98.51 6,62 2.19
168 Flutriafol 0.20 0.9953 N/A N/A N/A 96.42 10,14 7.37 105.15 9,45 8.63 90.02 8,07 2.90 96.88 17,53 0.89
169 Fluvalinate tau 4.00 0.9356 N/A N/A N/A N/A N/A N/A N/A N/A N/A 90.97 7,25 5.31 106.96 6,69 10.74
170 Fonofos 0.40 0.9924 N/A N/A N/A 104.18 13,29 14.80 101.25 11,79 6.87 87.63 7,29 10.09 97.22 6,69 4.61
171 Formetanate 0.10 0.9967 106.33 13,02 9.84 96.75 14,29 0.48 94.60 10,34 0.85 109.06 7,56 4.34 100.01 6,95 5.73
172 Fosthiazate 0.10 0.9972 106.58 11,43 10.48 97.01 9,22 10.28 95.35 8,80 6.45 101.87 15,78 5.69 96.64 14,66 1.77
173 Heptachlor 0.80 0.9722 N/A N/A N/A N/A N/A N/A 87.12 8,39 4.92 139.37 7,28 14.85 92.22 14,83 8.29
174 Hexachlorobencene 0.20 0.9858 N/A N/A N/A 99.79 9,37 9.45 105.21 8,36 5.94 93.97 16,62 10.01 93.24 15,11 8.38
175 Hexachlorocyclohexane (alpha) 0.40 0.9818 N/A N/A N/A N/A N/A N/A 104.74 10,64 5.92 104.70 13,30 11.16 102.65 6,65 9.23
176 Hexachlorocyclohexane (beta) 0.40 0.9456 N/A N/A N/A N/A N/A N/A 113.08 7,52 6.39 132.60 13,78 14.13 109.11 14,55 9.81
177 Hexachlorocyclohexane (delta) 0.20 0.9803 N/A N/A N/A 78.98 14,62 7.89 103.75 10,97 5.86 108.30 13,54 11.54 100.42 6,69 9.03
178 Hexaclorocyclohexane (gamma. lindane) 1.20 0.9788 N/A N/A N/A N/A N/A N/A 74.44 10,23 4.20 116.82 7,46 12.45 109.76 6,66 9.87
179 Hexaconazole (two isomers) 0.80 0.9956 N/A N/A N/A N/A N/A N/A 102.27 13,88 4.57 99.87 7,28 3.77 100.02 6,65 4.07
180 Hexaflumuron 0.40 0.9942 N/A N/A N/A 108.89 9,42 12.82 90.01 9,26 4.34 105.96 7,25 4.78 101.95 16,19 1.84
181 Hexythiazox 0.10 0.9901 100.56 8,48 12.26 92.79 9,89 0.73 88.30 9,01 12.34 108.98 7,31 4.58 101.78 15,67 2.78
182 Imazalil (enilconazole) 0.40 0.9962 N/A N/A N/A 109.11 10,51 1.10 99.07 9,60 0.11 105.22 14,79 1.79 100.07 17,30 5.52
183 Imidacloprid 0.80 0.9952 N/A N/A N/A N/A N/A N/A 87.81 15,08 2.99 104.63 7,28 11.64 96.04 6,63 2.58
184 Indeno [1.2.3-cd] pyrene 0.40 0.9919 N/A N/A N/A N/A N/A N/A 104.74 9,05 5.92 104.70 13,91 11.16 102.65 15,55 9.23
185 Indoxacarb 0.20 0.9936 N/A N/A N/A 107.04 14,47 9.81 90.81 17,33 0.63 104.94 16,20 0.90 100.08 6,69 2.82
186 Iprodione 4.00 0.9910 N/A N/A N/A N/A N/A N/A N/A N/A N/A 92.28 16,39 18.00 99.85 6,62 5.16
187 Iprovalicarb 0.20 0.9976 N/A N/A N/A 104.86 13,80 1.64 96.91 14,24 4.68 104.31 6,64 5.23 99.02 7,01 2.18
188 Isocarbophos 1.60 0.9921 N/A N/A N/A N/A N/A N/A N/A N/A N/A 97.94 14,54 9.86 101.76 14,94 7.87
189 Isofenphos methyl 0.40 0.9915 N/A N/A N/A 109.93 9,31 13.09 103.10 9,03 4.81 90.82 16,19 8.17 97.95 17,33 9.64
190 Isoprothiolane 0.10 0.9964 116.56 8,05 1.22 88.49 11,32 14.49 97.12 9,55 1.20 104.61 17,73 4.03 98.25 16,45 3.16
191 Ivermectin B1a 1.60 0.9537 N/A N/A N/A N/A N/A N/A N/A N/A N/A 105.65 17,48 10.35 105.44 6,85 17.66
192 Josamycin 0.40 0.9963 N/A N/A N/A 116.58 9,84 9.00 103.29 9,03 8.32 100.89 6,75 3.99 97.02 14,41 4.09
193 Ketoprofen 0.40 0.9947 N/A N/A N/A 111.09 13,69 9.48 91.37 15,03 5.33 104.97 16,90 2.64 95.12 6,88 4.68
194 Kresoxim methyl 1.20 0.9954 N/A N/A N/A N/A N/A N/A 102.98 15,93 5.45 88.44 6,70 7.22 96.75 6,67 3.56
195 Leptophos 0.80 0.9941 N/A N/A N/A N/A N/A N/A 101.99 16,06 1.71 98.45 6,98 9.13 98.20 6,83 6.65
196 Levamisole 0.20 0.9928 N/A N/A N/A 117.03 9,11 15.55 93.61 9,12 5.55 101.49 6,99 1.47 94.01 15,02 3.40
197 Lincomycin 0.40 0.9954 N/A N/A N/A 107.94 10,04 20.27 92.20 9,04 10.96 106.37 6,74 7.35 97.78 16,09 7.36
198 Linuron 0.20 0.9950 N/A N/A N/A 111.70 9,18 8.45 96.83 9,31 11.03 104.59 17,99 2.83 97.46 13,85 1.94
199 Lufenuron 0.40 0.9451 N/A N/A N/A 124.88 12,48 1.73 104.02 14,96 4.07 76.66 19,41 9.50 108.83 6,75 6.81
200 Malaoxon 0.10 0.9968 105.72 13,29 7.33 98.47 10,73 10.38 93.12 9,21 5.62 103.41 6,91 5.54 96.61 13,88 1.87
201 Malathion 0.20 0.9956 N/A N/A N/A 102.68 15,17 2.06 108.09 15,52 6.64 108.81 6,62 6.47 95.13 6,74 1.66
202 Mandipropamid 0.10 0.9965 115.12 12,98 1.19 88.72 12,74 4.12 94.24 16,17 0.83 104.13 6,65 1.48 97.38 6,62 1.67
203 Marbofloxacin 2.00 0.9589 N/A N/A N/A N/A N/A N/A N/A N/A N/A 58.20 8,81 13.63 95.33 6,67 21.85
204 Mebendazole 0.10 0.9960 139.72 14,34 0.62 93.53 9,81 2.13 93.17 9,63 5.68 104.77 16,51 3.77 97.25 14,46 2.70
205 Mefenamic acid 0.40 0.9938 N/A N/A N/A 111.93 10,36 4.50 97.29 9,33 11.22 106.39 15,98 0.91 101.74 16,63 0.41
206 Mefenoxam (metalaxyl-M) 0.10 0.9974 104.72 14,28 6.08 101.99 9,15 10.56 95.87 9,02 4.94 103.12 15,00 7.93 96.94 15,42 2.84
207 Meloxicam 0.20 0.9916 N/A N/A N/A 105.76 13,99 8.34 103.10 16,06 8.66 103.87 15,74 0.35 95.21 6,62 7.62
208 Mepanipyrim 0.40 0.9940 N/A N/A N/A 112.41 9,22 16.49 100.23 9,21 5.60 86.88 7,31 4.08 98.52 18,16 5.19
209 Mepiquat 0.40 0.9961 N/A N/A N/A 116.63 13,85 16.83 102.27 15,30 6.19 109.64 15,10 6.19 98.75 6,68 1.89
210 Metaflumizone 0.20 0.9538 N/A N/A N/A 117.95 13,04 7.80 110.07 14,54 14.54 78.67 7,94 1.92 108.66 7,10 15.31
211 Metaldehyde 4.00 0.9883 N/A N/A N/A N/A N/A N/A N/A N/A N/A 93.85 6,69 11.49 99.36 7,06 5.12
212 Metconazole 0.10 0.9972 112.89 17,30 7.83 90.40 10,89 3.31 94.39 9,51 3.75 106.51 6,73 5.49 99.30 7,31 1.11
213 Methamidophos (two isomers) 1.20 0.9914 N/A N/A N/A N/A N/A N/A 106.70 9,02 11.46 118.60 6,73 4.89 100.44 7,26 3.27
214 Methidathion 0.10 0.9971 103.57 9,74 14.60 93.56 11,22 7.71 97.65 9,08 0.47 105.01 15,31 4.15 98.65 7,31 3.48
215 Methiocarb 0.10 0.9988 102.06 8,49 8.48 80.51 15,96 14.62 104.48 15,11 0.95 102.47 15,17 6.24 99.13 15,56 0.40
216 Methiocarb-sulfoxide 0.80 0.9983 N/A N/A N/A N/A N/A N/A 106.81 9,41 3.29 100.84 16,38 3.36 99.34 7,92 2.12
217 Methomyl 0.40 0.9957 N/A N/A N/A 123.44 12,82 2.09 97.84 14,07 5.96 103.37 18,15 3.88 97.62 16,66 3.36
218 Methomyl oxime 8.00 0.9878 N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A 104.43 16,22 11.23
219 Methoxyfenozide 0.10 0.9970 101.72 8,47 12.57 94.61 12,59 7.91 92.06 16,58 4.97 107.21 16,10 4.63 98.53 14,79 5.72
220 Metoxychlor 0.80 0.9654 N/A N/A N/A N/A N/A N/A 103.00 9,01 4.49 107.95 6,76 4.82 99.17 7,25 1.81
221 Metrafenone 0.10 0.9961 105.81 19,69 4.81 96.19 10,87 16.34 92.34 9,58 1.92 104.28 6,62 2.67 97.90 7,25 4.32
222 Metronidazole 0.80 0.9962 N/A N/A N/A N/A N/A N/A 98.63 9,76 3.50 102.00 6,68 8.71 95.00 7,37 3.36
223 Mevinphos (phosdrin) 0.80 0.9915 N/A N/A N/A N/A N/A N/A 107.53 13,72 1.76 101.38 6,92 3.71 96.27 16,29 4.50
224 Mirex 2.00 0.9549 N/A N/A N/A N/A N/A N/A N/A N/A N/A 94.53 15,92 10.07 80.16 9,18 7.21
225 Monocrotophos 0.80 0.9965 N/A N/A N/A N/A N/A N/A 103.97 8,42 2.26 101.05 18,14 3.31 98.38 16,59 0.70
226 Myclobutanil 0.10 0.9951 124.02 8,55 14.29 90.40 14,35 1.18 93.06 10,29 11.51 104.50 14,50 1.48 97.54 14,00 1.84
227 N-(2.4-dimethylphenyl)-N’-methylformamidine (DMPF. metabolite of amitraz) 0.80 0.9974 N/A N/A N/A N/A N/A N/A 97.86 8,07 10.59 103.78 14,78 4.26 97.74 15,81 2.58
228 N.N-dimethylformamidine (DMF. metabolite of amitraz) 1.20 0.9835 N/A N/A N/A N/A N/A N/A 100.61 13,54 3.89 89.22 6,62 8.12 94.96 7,43 5.62
229 N.N-Dimethyl-N'-p-tolylsulphamide (DMST. metabolite of tolyfluanid) 0.20 0.9972 N/A N/A N/A 103.04 10,88 5.68 93.42 10,84 1.84 103.03 16,30 5.97 96.86 7,99 1.30
230 Nafcillin 0.80 0.9937 N/A N/A N/A N/A N/A N/A 88.13 14,49 4.44 108.84 6,82 0.54 103.15 7,68 2.36
231 Naphtalene 0.80 0.9321 N/A N/A N/A N/A N/A N/A 101.12 8,54 2.09 101.73 6,83 2.23 109.08 14,76 3.83
232 Naproxen 1.60 0.9915 N/A N/A N/A N/A N/A N/A N/A N/A N/A 103.39 6,66 13.15 101.78 7,24 7.98
233 Nitenpyram 2.00 0.9983 N/A N/A N/A N/A N/A N/A N/A N/A N/A 95.74 12,88 1.32 98.39 13,54 2.80
234 Novobiocin 0.80 0.9906 N/A N/A N/A N/A N/A N/A 103.08 7,97 18.91 105.94 9,44 19.94 94.20 16,68 2.89
235 Nuarimol 0.20 0.9907 N/A N/A N/A 109.73 12,42 0.51 97.78 10,16 3.72 90.15 10,54 2.92 99.33 14,45 13.10
236 Ofurace 0.10 0.9950 116.80 13,54 2.28 101.16 9,23 4.08 92.59 10,84 1.49 103.20 9,09 6.63 96.53 7,41 0.65
237 Omethoate 0.40 0.9955 N/A N/A N/A 123.46 9,26 4.50 92.85 14,57 13.56 103.56 14,05 4.38 97.89 7,34 1.03
238 Oxadixyl 0.20 0.9968 N/A N/A N/A 104.76 9,57 3.73 95.70 11,92 0.86 103.01 13,24 5.95 95.73 7,27 2.17
239 Oxamyl 0.40 0.9963 N/A N/A N/A 121.94 12,38 6.94 100.43 9,24 6.59 100.86 15,07 1.70 97.44 13,92 1.86
240 Oxfendazole 0.10 0.9958 127.49 9,14 3.24 103.94 9,83 7.55 89.18 10,70 3.62 100.67 15,04 7.94 96.27 7,42 1.82
241 Oxolinic acid 0.20 0.9878 N/A N/A N/A 115.69 14,38 16.83 83.19 8,62 3.27 93.60 11,38 7.48 91.97 13,85 12.34
242 Oxydemeton methyl 0.40 0.9957 N/A N/A N/A 121.11 14,05 6.52 92.99 8,25 1.58 101.52 9,52 5.54 97.61 15,88 2.85
243 Oxyfluorfen 0.40 0.9951 N/A N/A N/A 111.90 12,27 10.58 104.83 9,18 6.06 89.81 11,13 8.87 97.95 15,20 6.39
244 Paclobutrazol 0.40 0.9967 N/A N/A N/A 116.18 9,54 1.19 93.47 14,62 0.60 101.83 9,58 2.63 98.88 7,40 0.81
245 Paraoxon methyl 1.60 0.9967 N/A N/A N/A N/A N/A N/A N/A N/A N/A 87.46 14,41 19.55 101.53 7,25 6.01
246 Parathion ethyl 1.20 0.9566 N/A N/A N/A N/A N/A N/A 104.49 13,49 4.82 89.57 9,37 14.20 96.19 7,67 3.90
247 Parathion methyl 0.80 0.9976 N/A N/A N/A N/A N/A N/A 108.54 9,72 8.23 92.53 12,51 19.31 100.15 13,94 12.02
248 PCB 28 0.10 0.9912 83.22 13,04 15.78 93.92 10,39 11.89 106.19 11,02 6.00 97.60 12,20 10.40 88.62 7,25 7.97
249 PCB 52 0.20 0.9902 N/A N/A N/A 104.04 15,11 10.65 98.92 8,87 5.59 92.35 15,12 9.84 93.96 13,69 8.45
250 PCB 77 0.20 0.9923 N/A N/A N/A 100.53 14,86 8.65 98.89 9,22 5.59 88.02 16,35 9.38 92.40 14,65 8.31
251 PCB 81 0.10 0.9850 110.87 13,67 12.33 81.87 13,56 7.45 115.62 7,80 6.53 91.34 9,29 9.73 89.92 14,75 8.09
252 PCB 101 0.20 0.9876 N/A N/A N/A 107.84 10,20 12.34 110.75 10,27 6.26 93.40 10,87 9.95 92.89 7,29 8.35
253 PCB 105 0.10 0.9789 118.45 12,59 4.12 103.80 9,79 9.54 107.96 10,72 6.10 94.53 9,54 10.07 80.16 7,58 7.21
254 PCB 114 0.20 0.9776 N/A N/A N/A 97.14 10,43 6.22 110.95 11,13 6.27 85.53 11,13 9.11 84.13 8,29 7.57
255 PCB 118 0.20 0.9833 N/A N/A N/A 93.43 15,84 9.87 116.88 9,41 6.60 88.80 14,30 9.46 86.10 16,14 7.74
256 PCB 123 0.40 0.9834 N/A N/A N/A 96.14 9,55 11.67 106.30 12,46 6.01 88.58 9,79 9.44 85.35 7,25 7.67
257 PCB 126 0.20 0.9789 N/A N/A N/A 108.37 12,34 12.09 106.86 8,54 6.04 90.82 15,17 9.68 79.34 11,78 7.13
258 PCB 138 0.10 0.9798 107.23 9,04 9.56 91.30 13,54 9.07 110.40 8,31 6.24 92.83 14,93 9.89 84.08 9,09 7.56
259 PCB 153 0.10 0.9766 117.78 9,83 8.73 83.70 15,17 4.97 124.77 9,02 7.05 89.77 15,53 9.57 85.65 10,85 7.70
260 PCB 156 0.20 0.9912 N/A N/A N/A 98.33 10,47 7.21 107.17 16,36 6.05 91.74 15,28 9.78 77.11 17,71 6.93
261 PCB 157 0.40 0.9789 N/A N/A N/A 93.22 10,60 6.54 107.96 15,32 6.10 91.26 9,70 9.72 79.99 15,86 7.19
262 PCB 167 0.10 0.9770 102.89 9,26 6.45 91.43 11,68 8.97 102.06 14,16 5.77 86.31 9,26 9.20 81.14 15,29 7.30
263 PCB 169 0.20 0.9758 N/A N/A N/A 109.07 12,62 11.56 107.45 9,51 6.07 86.95 10,36 9.26 90.77 9,14 8.16
264 PCB 180 0.10 0.9807 119.51 8,34 20.01 87.43 12,13 10.76 113.14 15,94 6.39 85.21 11,75 9.08 95.03 13,54 8.55
265 PCB 189 0.10 0.9723 110.12 8,68 12.45 97.91 15,11 6.22 96.96 9,32 5.48 88.62 12,49 9.44 87.18 9,24 7.84
266 Penconazole 0.40 0.9930 N/A 114.19 13,25 14.47 101.18 9,00 3.31 91.43 10,09 1.78 99.02 9,49 10.75
267 Pencycuron 0.10 0.9968 97.11 8,84 9.23 94.99 12,74 13.51 93.82 9,10 3.87 105.44 12,04 6.20 97.74 9,16 0.70
268 Pendimethalin 0.80 0.9902 N/A N/A N/A N/A N/A N/A 106.58 16,84 2.61 88.47 15,67 3.62 97.69 16,40 0.06
269 Penicillin G 2.00 0.9903 N/A N/A N/A N/A N/A N/A N/A N/A N/A 117.02 13,91 3.71 97.77 12,92 3.62
270 Penicillin V 2.00 0.9917 N/A N/A N/A N/A N/A N/A N/A N/A N/A 105.81 13,39 2.98 97.69 15,53 3.59
271 Permethrin 1.20 0.9889 N/A N/A N/A N/A N/A N/A 101.46 9,10 0.12 87.27 10,84 2.23 101.87 9,16 17.84
272 Phenanthrene 0.20 0.9678 N/A N/A N/A 109.89 10,49 13.76 106.65 16,96 6.02 92.56 10,39 9.86 95.32 14,63 8.57
273 Phenylbutazone 1.60 0.9721 N/A N/A N/A N/A N/A N/A N/A N/A N/A 113.13 9,97 6.52 65.14 12,76 6.05
274 Phosalone 0.20 0.9961 N/A N/A N/A 98.37 13,12 4.61 92.71 10,27 2.58 107.98 9,30 4.93 101.62 8,94 1.06
275 Phosmet 0.20 0.9972 N/A N/A N/A 98.92 13,74 3.15 93.00 9,82 2.84 104.52 14,39 5.06 98.67 9,58 1.56
276 Phosmet oxon 0.20 0.9993 N/A N/A N/A 95.79 10,14 7.39 102.23 14,85 5.34 102.16 9,29 5.78 99.08 15,44 1.95
277 Piperacillin 0.40 0.9793 N/A N/A N/A N/A N/A N/A N/A N/A N/A 96.34 11,70 1.45 98.60 15,17 6.10
278 Pirimicarb 0.10 0.9977 105.98 8,04 2.51 98.18 10,71 6.09 95.11 15,17 5.23 102.97 10,72 4.86 97.54 15,39 1.81
279 Pirimiphos ethyl 0.10 0.9883 104.58 15,84 12.37 98.69 14,95 9.94 97.93 9,00 0.38 104.83 10,74 4.05 98.96 9,62 2.64
280 Pirimiphos methyl 0.10 0.9944 112.73 15,00 0.58 93.49 10,21 1.96 106.42 14,32 3.74 89.01 9,11 3.18 98.28 16,06 5.62
281 Prochloraz 0.10 0.9947 125.26 18,00 18.57 91.55 13,09 1.08 87.91 9,80 7.63 100.57 9,08 13.10 97.13 9,11 2.15
282 Procymidone 1.60 0.9947 N/A N/A N/A N/A N/A N/A N/A N/A N/A 80.19 15,87 6.54 100.94 9,20 5.65
283 Profenofos 0.10 0.9941 111.06 7,48 4.52 92.80 15,13 3.54 96.49 9,29 1.38 106.87 14,90 3.35 98.58 9,03 3.48
284 Propamocarb 0.40 0.9959 N/A N/A N/A 122.72 9,79 9.24 97.58 15,13 4.21 97.03 14,92 10.35 96.69 14,18 1.39
285 Propargite 0.10 0.9936 100.21 8,65 2.94 95.89 9,50 5.23 96.17 15,13 7.55 109.05 11,86 5.19 100.09 15,81 2.82
286 Propiconazole 0.40 0.9932 N/A N/A N/A 130.04 9,40 1.49 99.77 14,15 3.82 102.03 10,74 0.34 99.32 14,78 0.40
287 Propoxur 0.10 0.9941 118.68 11,02 14.25 92.88 13,46 13.27 90.94 9,34 1.25 101.89 9,97 6.43 96.39 8,93 1.71
288 Propyzamide (pronamide) 0.10 0.9955 135.09 10,13 25.43 82.62 12,64 4.33 89.32 18,24 8.08 102.57 9,70 4.21 98.22 15,95 2.04
289 Proquinazid 0.20 0.9808 N/A N/A N/A 121.75 13,90 4.37 100.38 9,85 10.36 89.96 11,39 7.16 96.95 9,40 16.39
290 Prothioconazol 0.40 0.9935 N/A N/A N/A 103.16 14,09 9.30 100.90 9,00 8.76 87.83 15,40 1.26 96.35 10,44 0.81
291 Prothiophos 0.40 0.9912 N/A N/A N/A 179.86 11,21 33.27 107.75 9,12 5.60 91.21 10,22 8.06 97.75 10,50 11.76
292 Pymetrozine 0.80 0.9952 N/A N/A N/A N/A N/A N/A 102.89 14,39 1.86 99.73 12,22 9.64 98.84 12,75 0.26
293 Pyraclostrobin 0.10 0.9970 105.05 8,46 0.95 88.71 11,51 20.65 95.80 15,56 0.93 104.40 13,96 8.09 97.82 13,51 0.60
294 Pyrazophos 0.10 0.9965 111.64 16,39 0.54 98.23 9,29 17.84 95.77 15,41 6.78 107.24 13,69 3.11 99.83 15,58 2.60
295 Pyrene 0.20 0.9880 N/A N/A N/A 96.42 13,97 9.56 93.61 9,19 5.29 93.37 13,91 9.95 91.07 9,54 8.19
296 Pyridaben 0.10 0.9973 105.99 9,65 29.54 86.82 10,63 8.41 97.27 11,31 14.36 111.71 10,40 5.14 100.32 13,91 1.83
297 Pyridaphenthion 0.20 0.9970 N/A N/A N/A 108.64 13,78 2.34 91.81 11,67 10.38 105.65 10,12 9.67 98.59 8,97 0.24
298 Pyrimethanil 0.20 0.9944 N/A N/A N/A 107.96 13,00 6.86 96.98 11,36 3.25 89.29 10,21 11.63 98.03 13,12 0.85
299 Pyriproxifen 0.10 0.9947 104.25 19,77 1.21 99.97 13,33 9.48 94.10 12,89 1.20 107.21 9,99 2.85 100.77 13,76 4.72
300 Quinalfos 0.20 0.9958 N/A N/A N/A 97.53 9,47 17.05 90.97 12,09 1.01 106.48 12,86 0.09 100.08 9,35 5.66
301 Quinoxyfen 0.10 0.9874 112.39 6,66 4.49 109.15 9,19 13.38 93.18 11,12 13.57 104.94 9,62 6.76 102.76 9,18 7.44
302 Rifampicin 0.80 0.9826 N/A N/A N/A N/A N/A N/A 111.21 10,43 10.64 95.28 14,86 0.19 89.73 11,01 5.48
303 Rotenone 0.40 0.9929 N/A N/A N/A 117.98 13,24 31.54 89.20 12,85 5.35 113.57 12,47 3.51 100.90 15,11 3.15
304 Roxithromycin 0.80 0.9971 N/A N/A N/A N/A N/A N/A 96.18 9,47 3.69 98.39 9,30 4.00 100.05 9,10 0.03
305 Sarafloxacin 4.00 0.9312 N/A N/A N/A N/A N/A N/A N/A N/A N/A 80.98 10,55 13.63 97.00 14,62 22.19
306 Simazine 0.20 0.9968 N/A N/A N/A 90.28 16,27 2.78 96.46 11,65 1.79 102.84 13,27 6.50 97.85 15,10 1.76
307 Spinosad (two isomers) 0.10 0.9970 119.58 11,44 9.10 84.56 15,73 4.96 94.98 13,13 9.89 100.78 16,05 7.72 96.81 12,98 1.95
308 Spiramycin (two isomers) 0.40 0.9915 N/A N/A N/A 131.47 9,05 5.94 95.33 9,51 14.39 106.27 13,21 4.78 97.03 10,02 3.05
309 Spirodiclofen 0.80 0.9869 N/A N/A N/A N/A N/A N/A 106.47 10,78 1.93 134.35 14,32 8.81 100.48 10,43 7.70
310 Spiromesifen 0.20 0.9911 N/A N/A N/A 96.47 9,96 13.07 101.29 9,33 5.45 115.81 8,86 4.16 100.68 10,51 2.72
311 Spiroxamine 0.10 0.9972 107.65 10,26 2.69 97.02 13,19 5.23 95.80 13,52 6.32 102.89 14,63 3.99 97.41 13,84 4.04
312 Strychnine 0.80 0.9963 N/A N/A N/A N/A N/A N/A 85.40 12,44 3.11 111.08 9,35 6.47 96.91 10,99 12.19
313 Sulfacetamide 0.40 0.9952 N/A N/A N/A 118.98 12,18 24.55 101.34 12,33 3.97 97.43 9,68 12.30 96.06 12,88 2.45
314 Sulfachloropiridacine 0.80 0.9930 N/A N/A N/A N/A N/A N/A 93.69 13,68 3.92 102.35 8,92 8.67 94.47 14,20 0.06
315 Sulfadiacine 0.80 0.9933 N/A N/A N/A N/A N/A N/A 97.95 12,68 8.67 95.92 10,00 14.59 98.24 12,94 6.24
316 Sulfadimetoxine 0.10 0.9962 122.34 7,01 0.77 104.34 9,54 10.58 94.70 10,65 12.38 103.45 15,28 9.68 96.93 10,87 1.88
317 Sulfadoxine 0.10 0.9949 129.86 7,48 12.83 92.91 9,62 4.59 92.41 10,95 6.06 104.11 12,45 8.47 95.40 9,22 4.00
318 Sulfameracine 0.20 0.9941 N/A N/A N/A 102.32 11,05 16.69 99.10 9,71 8.73 105.86 8,98 9.54 95.49 9,31 1.52
319 Sulfametacine 0.20 0.9939 N/A N/A N/A 98.96 12,83 1.51 97.49 11,61 3.97 103.52 8,92 8.64 95.26 13,20 1.45
320 Sulfametizole 0.80 0.9864 N/A N/A N/A N/A N/A N/A 100.19 10,28 0.31 103.59 8,94 10.59 91.01 9,92 3.80
321 Sulfametoxazole 0.40 0.9948 N/A N/A N/A 112.21 12,92 9.16 94.31 14,06 6.41 103.91 10,23 10.13 94.74 14,50 3.86
322 Sulfametoxipiridacine 0.40 0.9940 N/A N/A N/A 104.29 13,02 13.05 98.89 13,20 19.85 105.96 12,95 6.19 95.01 14,99 3.00
323 Sulfamonomethoxine 1.20 0.9913 N/A N/A N/A N/A N/A N/A 111.11 11,11 3.29 93.85 13,38 10.90 96.63 14,16 2.94
324 Sulfapyridine 0.40 0.9930 N/A N/A N/A 109.50 9,43 3.94 103.66 9,59 8.63 98.18 13,72 7.97 95.32 11,29 0.42
325 Sulfaquinoxaline 0.40 0.9962 N/A N/A N/A 115.47 9,35 15.86 92.67 9,83 12.76 101.15 14,97 7.60 96.86 10,75 0.16
326 Sulfatiazole 0.40 0.9922 N/A N/A N/A 109.32 10,34 18.92 87.79 11,88 0.71 96.90 9,58 11.07 96.24 9,72 1.08
327 Sulfisoxazole 0.80 0.9965 N/A N/A N/A N/A N/A N/A 93.73 12,52 5.51 101.82 14,33 5.95 95.32 14,43 1.90
328 Tebuconazole 0.80 0.9949 N/A N/A N/A N/A N/A N/A 92.08 10,26 8.58 98.28 9,74 5.09 98.61 9,22 4.53
329 Tebufenocide 0.10 0.9947 92.74 14,93 17.37 89.88 15,24 5.86 96.15 11,17 6.53 105.61 9,47 4.63 101.10 12,57 8.24
330 Tebufenpyrad 0.10 0.9950 111.56 9,92 2.79 86.18 13,25 9.05 95.86 12,29 4.97 106.62 9,27 4.29 100.57 6,66 3.07
331 Teflubenzuron 1.20 0.9860 N/A N/A N/A N/A N/A N/A 97.01 11,66 13.94 94.86 9,78 4.53 99.61 6,65 5.63
332 Tefluthrin 0.10 0.9937 97.69 9,68 14.14 104.85 10,00 3.87 107.14 10,41 2.51 88.84 15,18 4.03 95.53 14,71 1.33
333 Telodrin (isobenzan) 0.80 0.9930 N/A N/A N/A N/A N/A N/A 93.03 9,80 11.99 92.60 16,28 21.17 101.82 16,65 10.96
334 Terbufos 0.20 0.9942 N/A N/A N/A 107.98 9,37 17.24 97.29 9,28 3.06 90.31 13,69 6.42 102.47 17,11 8.75
335 Terbuthylazine 0.40 0.9961 N/A N/A N/A 98.38 12,63 4.02 93.37 14,53 2.45 91.01 13,07 11.41 99.87 6,61 3.75
336 Tetrachlorvinphos 0.40 0.9984 N/A N/A N/A 105.27 9,21 8.36 93.03 9,91 10.04 104.96 9,12 2.97 101.50 14,60 6.48
337 Tetraconazole 0.20 0.9878 N/A N/A N/A 96.23 12,80 9.69 101.26 13,96 5.09 89.84 14,01 3.49 99.52 6,84 8.62
338 Tetradifon 0.40 0.9912 N/A N/A N/A 110.62 12,25 10.72 103.75 14,09 8.41 91.10 9,45 2.57 100.16 6,91 8.47
339 Tetramethrin 1.60 0.9871 N/A N/A N/A N/A N/A N/A N/A N/A N/A 85.18 10,80 2.32 98.04 7,06 1.46
340 Thiabendazole 0.20 0.9953 N/A N/A N/A 99.82 9,60 4.72 88.38 9,69 3.77 101.10 9,07 5.74 99.15 18,69 4.46
341 Thiacloprid 0.20 0.9972 N/A N/A N/A 107.76 9,74 2.80 94.23 9,09 6.03 102.23 8,91 5.37 97.17 17,95 1.87
342 Thiamethoxam 0.80 0.9968 N/A N/A N/A N/A N/A N/A 103.40 9,05 6.94 101.22 14,16 5.43 98.61 16,69 1.97
343 Thiophanate methyl 0.20 0.9968 N/A N/A N/A 102.31 13,05 6.57 94.75 16,70 4.03 103.59 14,67 7.43 97.52 7,00 3.77
344 Tolclofos methyl 0.10 0.9922 116.17 11,56 5.73 100.20 9,86 4.71 96.78 9,59 17.32 92.67 16,21 6.45 99.05 14,51 10.76
345 Tolfenamic acid 0.40 0.9917 N/A N/A N/A 106.53 12,83 9.72 105.64 15,03 7.99 98.88 14,27 0.15 104.07 6,78 3.23
346 Triadimefon 0.40 0.9967 N/A N/A N/A 115.55 12,00 19.61 95.64 14,82 2.87 100.72 9,18 4.89 99.14 6,64 0.92
347 Triadimenol 0.40 0.9949 N/A N/A N/A 108.82 13,57 19.22 90.50 14,42 10.27 100.86 14,76 8.82 99.02 6,64 8.06
348 Triazophos (hostathion) 0.10 0.9976 97.70 9,50 9.62 97.52 9,35 2.53 96.68 9,01 10.04 103.87 9,67 4.89 98.73 17,46 3.23
349 Trichlorfon 1.20 0.9981 N/A N/A N/A N/A N/A N/A 99.76 9,02 19.77 100.02 8,98 0.34 98.66 16,06 0.59
350 Trifloxystrobin 0.10 0.9950 79.68 8,31 16.36 99.02 9,33 11.67 105.21 9,00 2.26 113.52 9,66 3.24 98.92 16,80 1.91
351 Triflumizole 0.10 0.9946 91.81 7,37 21.56 92.12 16,13 7.68 94.83 16,24 2.17 107.86 10,07 1.06 100.97 6,86 1.32
352 Triflumuron 0.40 0.9954 N/A N/A N/A 109.58 9,67 9.83 97.28 9,37 3.38 106.90 13,20 12.75 102.17 15,84 3.65
353 Trifluralin 0.20 0.9928 N/A N/A N/A 113.51 14,55 1.27 105.71 15,05 16.83 85.71 15,12 16.24 99.77 6,81 16.19
354 Trimethoprim 0.80 0.9974 N/A N/A N/A N/A N/A N/A 98.59 16,81 5.49 108.01 15,11 4.37 96.85 7,03 0.59
355 Triticonazole 0.40 0.9948 N/A N/A N/A 119.81 11,96 4.08 97.96 15,07 9.40 99.78 14,17 1.39 98.33 6,91 1.25
356 Tylmicosin 1.60 0.9955 N/A N/A N/A N/A N/A N/A N/A N/A N/A 103.10 13,68 3.57 95.24 14,57 6.28
357 Tylosin 0.80 0.9975 N/A N/A N/A N/A N/A N/A 105.10 9,03 6.25 103.84 14,83 4.75 99.16 18,48 5.44
358 Vinclozolin 0.20 0.9936 N/A N/A N/A 112.53 9,07 17.45 95.98 9,13 6.12 85.39 17,83 5.12 97.78 16,65 0.80
359 Warfarin 0.10 0.9962 106.32 9,23 20.28 90.08 13,61 15.11 92.87 16,86 4.58 103.35 13,18 3.78 98.30 6,73 0.08
360 Zoxamide 0.40 0.9960 N/A N/A N/A 126.95 9,61 10.37 94.83 9,07 3.13 101.49 12,65 5.65 98.29 15,52 1.08

Fig. 1 shows the effect that the components of the matrix have on the quantification of each chemical substance, to demonstrate the need to perform said quantification with calibrators prepared in a white matrix for at least 45% of the compounds. Results are shown as a relative percentage quantified by ACN calibration curve. When the differential is greater 20% or −20%, matrix interference is considered to exist. For clarity, the compounds are identified numerically, from 1 to 360, as they are numbered in Table 1. Raw data of the six charts of this figure are provided in the supplementary file 2.

Fig. 1.

Fig. 1

Matrix effect (%) of 360 compounds included on the method

Tables 2 and 3 show the quantitative results of the contaminants found in 36 barn owls (Tyto Alba) and Tables 4 and 5, show those found in 112 common kestrels (Falco tinnunculus). The results of persistent and non-persistent organic pollutants are presented separately. For clarity, only contaminants that have tested positive for at least one individual are shown. Raw data of the quantification of the 360 pollutants in these 187 birds are provided in the supplementary file 3.

Table 2.

Concentrations of persistent organic pollutants found in whole blood (ng/ml) of a series of barn owls sampled in Castilla–Leon (Spain) during 2018 and 2019.

Acenaphtylene BDE-47 BDE-100 BDE-153 BDE-154 BDE-99 Dichlorodiphenyldichloroethylene (p,p’ DDE) Fluoranthene Fluorene Hexachlorobencene PCB 118 PCB 138 PCB 153 PCB 156 PCB 167 PCB 180 PCB 189 Phenanthrene Pyrene
Barn owl 01 0.39 0.14 0.28 0.68 1.51 0.32 0.33 0.42 0.46 0.73
Barn owl 02 0.19 0.33 0.20 0.10 0.68 3.06 0.53 0.83 0.20 2.22 3.21 0.23 0.25 5.81 0.13 0.54 0.20
Barn owl 03 0.32 0.20 0.10 0.20 0.09 0.35 0.10 0.10 0.09 0.49 0.20
Barn owl 04 0.10 0.41 0.10 0.12 0.12 0.29 0.20
Barn owl 05 0.22 0.20 0.12 0.20 0.10 0.40 0.21 0.60 0.75 0.57
Barn owl 06 0.13 0.40 0.38 0.14 0.20 0.22 0.46 0.34
Barn owl 07 0.93 0.32 0.56 0.28 0.42 0.58 0.42 0.29
Barn owl 08
Barn owl 09 0.25 0.93 0.44 0.25 0.35 0.41 0.40 0.21
Barn owl 10 0.49 0.52 0.48 0.25 0.32 0.38 0.65 0.60
Barn owl 11 0.53 0.26 1.31 0.90 0.20 0.18 0.20 0.28 1.57 0.45
Barn owl 12 0.10 0.22 1.05 0.43 0.09 1.24 0.27
Barn owl 13 0.55 0.71 1.18 0.19
Barn owl 14 1.13 0.80 0.21
Barn owl 15 0.35 0.78 0.71 0.59 0.20
Barn owl 16 0.16 1.30 0.20 0.10 0.14 1.12 0.21
Barn owl 17 0.38 0.77 0.20 0.39 0.20
Barn owl 18 0.86 0.24 0.50 0.20
Barn owl 19 1.12 0.34 1.88 0.27
Barn owl 20 0.36 0.67 0.58 0.21
Barn owl 21 0.27 1.27 1.06 0.44
Barn owl 22 0.34 0.99 0.10 1.06 0.23
Barn owl 23 0.19 0.72 0.91 0.20
Barn owl 24 0.20 0.64 0.41 0.20
Barn owl 25 0.10 0.28 1.29 0.36 0.10 2.25 0.30
Barn owl 26 0.33 0.26 0.62 1.40 0.26
Barn owl 27 0.14 0.43 0.92 0.61 1.32 0.19
Barn owl 28 0.99 0.57 0.20
Barn owl 29 0.42 0.44 1.00 0.17 0.27 0.39 0.54 0.20
Barn owl 30 1.11 1.27 1.75 0.41 0.48 0.55 0.81 0.20
Barn owl 31 0.81 0.38 0.52 0.20
Barn owl 32 0.30 1.50 0.23 2.23 0.26
Barn owl 33 0.79 0.35 0.85 0.20
Barn owl 34 0.74 0.99 0.23
Barn owl 35 1.05 0.38 0.99 0.26
Barn owl 36 0.80 0.73 0.19

Table 3.

Concentrations of non-persistent organic pollutants found in whole blood (ng/ml) of a series of barn owls sampled in Castilla–Leon (Spain) during 2018 and 2019.

2-Phenylphenol Benalaxyl Brodifacoum Bromadiolone Coumatetralyl Dexamethasone Difenacoum Enrofloxacin Eprinomectin Fenbendazole Flocoumafen Flumequine Metaflumizone Simazine Sulfadiacine Thiacloprid
Barn owl 01 0.20 0.80 0.40 1.20 0.20 0.14 13.69
Barn owl 02 0.21 0.13 1.35 0.41
Barn owl 03 0.33
Barn owl 04 0.20 0.10 0.63
Barn owl 05 0.24
Barn owl 06 0.20
Barn owl 07 0.20
Barn owl 08
Barn owl 09 0.36 0.31
Barn owl 10 0.27 0.24
Barn owl 11 5.29
Barn owl 12 5.88 0.10
Barn owl 13 4.19 0.10 2.57
Barn owl 14 1.71
Barn owl 15 0.34
Barn owl 16 2.60
Barn owl 17 0.24
Barn owl 18 0.34 0.33
Barn owl 19 4.27
Barn owl 20 0.29 0.20 0.40
Barn owl 21 1.35 0.10
Barn owl 22 0.56 0.21
Barn owl 23 0.32 0.09
Barn owl 24 0.32 0.39 0.20
Barn owl 25 5.20 0.40 0.43
Barn owl 26 3.43
Barn owl 27 2.20
Barn owl 28 0.33 0.10 111.36
Barn owl 29 0.38 6.37
Barn owl 30 0.38
Barn owl 31 0.32
Barn owl 32 4.25
Barn owl 33 0.41 0.15 0.10
Barn owl 34 0.37
Barn owl 35 0.63 0.40
Barn owl 36 0.51

Table 4.

Concentrations of persistent organic pollutants found in whole blood (ng/ml) of a series of common kestrels sampled in Castilla–Leon (Spain) during 2018 and 2019.

Acenaphthene Acenaphtylene BDE99 BDE100 BDE153 BDE154 BDE183 Dichlorodiphenyldichloroethane(p,pDDD) Dichlorodiphenyldichloroethylene(p,pDDE) Fluoranthene Fluorene Hexachlorobencene Hexachlorocyclohexane(alpha) Hexaclorocyclohexane(beta) Naphtalene PCB28 PCB101 PCB105 PCB118 PCB138 PCB153 PCB156 PCB167 PCB180 PCB189 Phenanthrene Pyrene
Common kestrel 01 0.23 0.21 0.10 4.40 0.29 0.89 0.61 0.20 0.20 0.49 1.83 2.74 0.20 0.25 0.22 0.09 1.16 0.91
Common kestrel 02 0.10 0.61 0.30
Common kestrel 03 0.72 0.25
Common kestrel 04 0.31 0.20 0.53 0.20
Common kestrel 05 0.62 0.40 0.36 1.26 0.20
Common kestrel 06 0.35 0.33 0.52 0.22 0.26 0.25 1.08 0.20
Common kestrel 07 0.37 0.34 0.25 0.29 0.28 0.54 0.20
Common kestrel 08 0.54 0.22 0.33 0.30 0.35 0.22 0.63 0.20
Common kestrel 09 0.21 0.28 0.44 0.20
Common kestrel 10
Common kestrel 11 0.10 0.10 0.41 0.56 0.27 0.17 0.33 0.37 1.19 0.20
Common kestrel 12 0.31 0.19 0.31 0.20
Common kestrel 13 0.34 0.57 0.20
Common kestrel 14 0.22 0.37 0.37 0.20
Common kestrel 15 0.20 0.40 0.34 0.55 0.20
Common kestrel 16 0.42 0.20 1.36 0.20
Common kestrel 17 0.45 0.85 0.20
Common kestrel 18 0.33 0.79 0.20
Common kestrel 19 0.35
Common kestrel 20
Common kestrel 21
Common kestrel 22 0.33 0.20 0.17 0.26 0.20
Common kestrel 23 0.23 0.19 0.32 0.20
Common kestrel 24 0.47 0.28 0.75 0.20
Common kestrel 25 0.10 0.55 0.20 0.10 0.09 0.16 0.79 0.20
Common kestrel 26 0.10 0.23 0.10 0.10 0.12 0.45 0.20
Common kestrel 27 0.17 0.29 0.36 0.11 0.10 1.30 0.28
Common kestrel 28 0.39 0.54 0.20 0.76 0.20
Common kestrel 29 0.10 0.36 0.47 0.09 0.57 0.20
Common kestrel 30 0.10 0.40 0.20 0.09 0.44 0.20
Common kestrel 31 0.27 0.54 0.55 0.20
Common kestrel 32 0.23 0.20 0.31 0.20
Common kestrel 33 0.10 0.20 0.20 0.10 0.11 0.30 0.20
Common kestrel 34 0.27 0.37 0.33 0.40 0.20
Common kestrel 35 0.42 0.10 0.83 0.38
Common kestrel 36 0.24 0.36 0.83 0.25
Common kestrel 37 0.20 0.09 0.25 0.25 0.39 2.67 0.57 0.23
Common kestrel 38 0.36 0.27 0.38 0.66 0.50 0.28
Common kestrel 39 0.25 0.58 0.53 1.55 0.31
Common kestrel 40 0.19 0.15 0.19 0.53 0.99 0.09 0.11 0.09 0.40 0.39
Common kestrel 41 0.28 0.66 0.63 0.95 0.09 0.15 0.10 0.96 0.43
Common kestrel 42 0.27 0.20 0.51 1.10 0.70 0.37
Common kestrel 43 0.31 1.02 0.32 1.97 0.47
Common kestrel 44 0.37 0.35 0.68 0.20 1.41 0.22
Common kestrel 45 0.65 0.91 0.57 0.32 0.10 0.10 0.10 1.01 0.21
Common kestrel 46 0.23 0.28 0.27 0.40 0.20
Common kestrel 47 0.34 0.33 0.73 0.20
Common kestrel 48 0.20 0.10 0.69 0.19 1.04 0.25
Common kestrel 49 0.10 0.31 0.20 0.10 0.09 0.86 0.21
Common kestrel 50 0.09 0.66 0.52 0.10 0.54 0.20
Common kestrel 51 0.54 0.27 0.44 0.21
Common kestrel 52 0.10 0.42 0.44 0.91 0.21
Common kestrel 53 0.51 0.78 0.45 0.20
Common kestrel 54 0.35 0.58 0.81 0.20
Common kestrel 55 0.38 0.38 0.48 1.14 0.09
0.19 0.19 1.27 0.24
Common kestrel 56 0.29 0.41 0.75 0.10 0.19 0.20 0.76 0.20
Common kestrel 57 0.83 0.64 1.02 0.17 0.33 0.35 0.53 0.25
Common kestrel 58 0.46 0.70 0.25
Common kestrel 59 0.65 0.57 0.22
Common kestrel 60 0.54 0.21 0.20
Common kestrel 61 0.35 0.36 0.35 0.20
Common kestrel 62 0.45 0.17 0.35 0.20
Common kestrel 63 0.32 0.23 0.38 0.20 0.13 0.36 0.44 0.51 0.70
Common kestrel 64 0.20 0.10 0.45 2.51 0.40 5.95 0.20 0.64 3.49 0.23 0.27 6.88 0.18 0.52 0.28
Common kestrel 65 0.45 1.40 0.59 5.49 0.26 0.82 2.83 0.20 0.19 2.80 1.45 0.29
Common kestrel 66 0.12 0.63 2.86 0.14 0.23 0.26 0.86 0.20
Common kestrel 67 0.11 0.41 2.72 0.18 0.49 0.10 0.69 0.85 0.20
Common kestrel 68 0.10 0.39 0.38 0.10 0.11 0.11 0.71 0.20
Common kestrel 69 0.48 0.39 0.10 0.20 0.27 0.62 0.20
Common kestrel 70 0.51 0.49 1.08 0.20
Common kestrel 71 2.03 0.32 2.63 0.10 0.20 0.24 0.83 0.09 0.90 0.38 0.20
Common kestrel 72 0.36 0.47 0.24 1.22 0.22
Common kestrel 73 0.31 0.31 0.38 0.20
Common kestrel 74 0.46 0.20 1.15 0.20
Common kestrel 75 0.35 0.46 0.38 0.39 0.20
Common kestrel 76 0.36 0.56 0.20
Common kestrel 77 0.10 0.57 0.56 0.10 0.73 0.24
Common kestrel 78 0.09 0.40 0.10 0.10 0.13 0.39 0.20
Common kestrel 79 0.45 0.39 0.74 0.20
Common kestrel 80 0.45 0.27 0.35 0.20
Common kestrel 81 0.36 0.47 0.79 0.25
Common kestrel 82 0.46 0.28 0.42 0.20
Common kestrel 83 0.26 0.41 0.46 0.34
Common kestrel 84 0.81 0.30 1.04 0.23
Common kestrel 85 0.61 0.35 0.56 0.21
Common kestrel 86 0.54 0.25 0.52 0.20
Common kestrel 87 0.24 0.55 0.99 0.59
Common kestrel 88 0.25 0.83 1.65 0.30
Common kestrel 89 0.09 0.46 0.13 0.26 0.26 0.33 0.21
Common kestrel 90 0.37 0.36 0.20 0.53 0.98 0.20 0.12 0.90 0.45 0.20
Common kestrel 91 0.23 0.12 0.20 0.10 0.20 4.29 0.42 0.17 0.50 2.87 5.17 0.49 0.36 6.80 1.05 0.25
Common kestrel 92 0.50 0.57 0.53 0.21
Common kestrel 93 0.21 0.42 0.49 0.44 0.20
Common kestrel 94 0.59 0.73 0.11 0.13 0.55 0.20
Common kestrel 95 0.10 0.11 0.29 0.59 0.10 0.10 1.04 0.36
Common kestrel 96 0.22 0.26 0.10 0.10 0.10 0.59 0.20
Common kestrel 97 0.26 0.51 0.53 0.81 0.10 0.65 0.22
Common kestrel 98 0.37 0.39 0.48 0.83 0.10 0.14 0.11 0.97 0.21
Common kestrel 99 0.37 0.15 0.35 0.44 0.13 0.19 0.24 0.98 0.21
Common kestrel 100 0.42 0.35 0.88 0.30
Common kestrel 101 0.44 0.31 0.40 0.41 0.34 0.20
Common kestrel 102 0.46 1.05 0.20
Common kestrel 103 0.37 0.21 0.23 0.47 0.20
Common kestrel 104 0.31 0.09 0.25 0.41 0.40 0.40
Common kestrel 105 0.29 0.33 0.51 0.27
Common kestrel 106
Common kestrel 107 0.09 0.10 0.18 0.39 0.29 0.20 0.26 0.62 0.39 0.20
Common kestrel 108 0.40 0.10 1.44 0.30 0.83 0.41 0.61 0.70 0.37 0.20
Common kestrel 109 0.42 0.22 0.43 0.51 0.10 0.24 0.36 0.25 0.20
Common kestrel 110 0.81 0.50 0.20 0.16 0.46 0.70 0.45 0.20
Common kestrel 111 0.51 0.10 0.57 0.79 0.20
Common kestrel 112 0.26 0.38 1.27 0.10 0.21 0.38 0.45 0.20

Table 5.

Concentrations of non-persistent organic pollutants in whole blood (ng/ml) of a series of common kestrels sampled in Castilla–Leon (Spain) during 2018 and 2019.

2-Phenylphenol Albendazole Atrazine Benalaxyl Brodifacoum Bromadiolone Coumachlor Coumaphos Coumatetralyl Difenacoum Difethialone Diphenylamine Enrofloxacin Fenbendazole Flumequine Levamisole Mebendazole Metaflumizone Metrafenone Simazine Sulfachloropiridacine Sulfadiacine Sulfapyridine
Common kestrel 01 0.20
Common kestrel 02 1.23 0.52
Common kestrel 03 2.25 0.10
Common kestrel 04 0.81 0.42
Common kestrel 05 1.31 0.10 0.51
Common kestrel 06 0.87 0.23 0.20
Common kestrel 07 0.52 0.25 0.31 0.20
Common kestrel 08 2.05 0.31 0.28 0.20
Common kestrel 09 0.58 0.21 0.33
Common kestrel 10 0.30 0.10
Common kestrel 11 1.73 0.80 0.37
Common kestrel 12 0.37 0.28
Common kestrel 13 0.59 0.11 0.28
Common kestrel 14 0.67 0.21 0.19
Common kestrel 15 0.73 0.10 5.84
Common kestrel 16 5.27 0.63 0.10 0.22
Common kestrel 17 3.90
Common kestrel 18 0.98 0.10 0.20
Common kestrel 19
Common kestrel 20 0.10 0.24
Common kestrel 21 0.17
Common kestrel 22 0.64 0.19
Common kestrel 23 1.07 0.21
Common kestrel 24 1.09
Common kestrel 25 1.20 0.80
Common kestrel 26 0.45 0.80
Common kestrel 27 1.04
Common kestrel 28 0.99 0.58
Common kestrel 29 0.52 0.40 0.19
Common kestrel 30 1.55 0.10 0.10 0.20
Common kestrel 31 0.78
Common kestrel 32 1.07 0.10
Common kestrel 33 0.82 0.23
Common kestrel 34 0.41 0.92
Common kestrel 35 1.14 0.20
Common kestrel 36 0.60
Common kestrel 37 0.36 0.10
Common kestrel 38 1.11
Common kestrel 39 4.91 0.10 0.50
Common kestrel 40 0.84
Common kestrel 41 1.55
Common kestrel 42 0.60
Common kestrel 43 2.35 0.33
Common kestrel 44 2.21 0.98 0.65
Common kestrel 45 1.80 0.80
Common kestrel 46 0.21 0.10
Common kestrel 47 0.32
Common kestrel 48 2.65 0.10 0.20
Common kestrel 49 0.91 13.02
Common kestrel 50 0.34
Common kestrel 51 0.60 0.80
Common kestrel 52 0.48
Common kestrel 53 0.32 0.10
Common kestrel 54 0.26 0.10
Common kestrel 55 1.56
Common kestrel 56 0.29
Common kestrel 57 0.20
Common kestrel 58 0.21
Common kestrel 59 0.60
Common kestrel 60 2.01
Common kestrel 61 0.70
Common kestrel 62 0.78
Common kestrel 63 0.21 0.41 1.20
Common kestrel 64 0.19 0.25
Common kestrel 65 0.24 0.25
Common kestrel 66 1.45
Common kestrel 67 1.09
Common kestrel 68 0.75 0.10
Common kestrel 69 1.00
Common kestrel 70 0.54
Common kestrel 71 0.99 32.73 0.42 0.80
Common kestrel 72 0.78
Common kestrel 73 0.68
Common kestrel 74 2.50
Common kestrel 75 0.20
Common kestrel 76 0.66
Common kestrel 77 0.59 0.16 0.22
Common kestrel 78 0.20 0.23 1.93 0.30 1.77 0.85
Common kestrel 79 1.32 0.20 0.20 0.10 0.29
Common kestrel 80 0.20 0.1 0.24
Common kestrel 81 1.20 0.26 0.23
Common kestrel 82 0.20 0.14 0.40
Common kestrel 83 0.20 0.14 0.10
Common kestrel 84 1.98 0.16 0.19
Common kestrel 85 0.37 0.16 0.10
Common kestrel 86 0.29 0.10 0.10
Common kestrel 87 0.32 0.46
Common kestrel 88 1.32 0.10
Common kestrel 89 0.30
Common kestrel 90 0.20
Common kestrel 91 2.99
Common kestrel 92 0.20 0.20
Common kestrel 93 0.20 0.10
Common kestrel 94 0.20
Common kestrel 95 0.39
Common kestrel 96 0.20
Common kestrel 97 0.43 0.20
Common kestrel 98 0.26 0.10 0.24
Common kestrel 99 0.20 0.10
Common kestrel 100 0.51 0.20
Common kestrel 101 0.29
Common kestrel 102 0.47 0.49
Common kestrel 103 0.60
Common kestrel 104 0.52
Common kestrel 105 0.42
Common kestrel 106
Common kestrel 107 0.20
Common kestrel 108 0.20
Common kestrel 109 0.45
Common kestrel 110 0.80 0.42
Common kestrel 111 2.09 0.82
Common kestrel 112 0.24

Experimental design, materials, and methods

Chemicals, reagents, and calibrators

Certified pure standards of the 360 chemicals included in the methodology (Dr Ehrestorfer, Augsburg, Germany; CPA Chem, Stara Zagora, Bulgaria; A2S – Analytical Standard Solutions, Staint Jean D'Illac, France; Sigma-Aldrich, Augsburg, Germany; Accustandard, New Haven, USA; and European Pharmacopoeia Reference Standards, Strasbourg, France) were individually prepared at 1 mg/ml in a suitable solvent. From those, three intermediate working solutions (by groups: pesticides, medicaments and COPs) containing all the analytes at 1 μg/ml was prepared. This working solution was employed to prepare 12-point calibration curve, either in 1% FA-ACN or in whole blood (a 1:1 mixture of chicken and goat blood, obtained from healthy animals in the Veterinary Faculty of the University of Las Palmas de Gran Canaria). The intermediate solution was also employed for preparing quality controls (QC) and all the fortification levels in blank matrix and extracted blank matrix, that were employed in the validation experiments. The salts for the QuEChERS extraction according to the AOAC method were acquired in commercial premixes from Agilent Technologies (Palo Alto, USA). Acetonitrile (ACN), methanol (MeOH), and FA were of the maximum purity available and were purchased from Honeywell (Charlotte, USA). Ammonium acetate was from Fisher (Fisher Scientific UK, Loughborough, UK). The water was prepared in the laboratory using an ultra purification system (Millipore, Molsheim, France).

Sample preparation

Two hundred fifty microliters whole blood from wild birds or blank matrix (goat + chicken whole blood) either fortified with the 360 analytes plus the internal standards (ISs), the ISs alone, or without fortification, were subjected to an AOAC-QuEChERS extraction method (one-step, without cleanup). The mixture of IS (acenaphthene-d10, chlorpyrifos-d10, chrysene-d12, diazinon-d10, PCB 200, and phenanthrene-d10 for the GC method, atrazine-d5, carbendazim-d3, cyromazine-d4, diazinon-d10, linuron-d3, and pirimicarb-d6 for the LC method) was added to all the tubes before the extraction. The samples were orbital shaken for 1 h, and then, 500 µl of 1% FA-ACN were added, before tubes were placed in an ultrasonic bath at room temperature for 20 min. Then, the QuEChERS salts (150 mg anhydrous magnesium sulfate and 37.5 mg sodium acetate) were added and, the tubes were vortexed 30 s and vigorously manually shaken for 60 s. After a 5 min centrifugation, the supernatant was filtered (0.2 µm) and used directly for chromatographic analyses. The optimization of the procedure is detailed in the main article [3].

Chromatographic analyses

Two complementary analyses were needed for the quantification of 360 environmental pollutants in whole blood. Thus, 234 compounds were analyzed by liquid chromatography and other 126 chemicals were analyzed by gas chromatography. Both techniques were tandem coupled to triple quadrupole mass spectrometry (LC-MS/MS and GC-MS/MS). All the equipment employed was from Agilent Technologies (Palo Alto, USA): UHPLC 1290 coupled to 6460 mass spectrometer for LC, and a 7890B GC coupled to 7010 mass spectrometer for GC. The chromatographic separations in LC were performed using an InfinityLab Poroshell 120 (2.1 mm × 100 mm, 2.7 µm). The stationary phase in GC consisted of two fused silica ultra-inert capillary columns Agilent HP-5MS (15 m × 0.25 mm i.d., 0.25 µm film thickness), that were connected by a purged union, to allow the backflushing. All the conditions in which these apparatus were operated, as well as the optimization procedure, are described in detail in the main article [3].

Validation

This article provides supporting information on the data of the validation process, which was carried out according to the criteria established in the SANTE and SWGTOX guide [1, 2] and, taking into account our previous experience in developing and validating chromatographic methods in complex biological matrices [4], [5], [6]. Although initially the experiments were carried out with chicken and goat blood separately, we found no significant differences. Therefore, we decided to use a 1: 1 mixture of both blood types to complete all validation experiments, following the recommendations of the SWGTOX guide. All the parameters of the validation process are shown in this article, except for the identity and selectivity parameters, which are shown in Table 1 of the main article [3], and carryover, which is also explained in the main article. As the blank matrix was not completely free of all of the contaminants, the signal of the blanks was subtracted from fortified samples in all the experiments.

Linearity was assessed within the range of concentrations that were considered appropriate for the purpose of biomonitoring (0.1 to 20 ng/ml). All the calibrators (12 points) were individually prepared in blank matrix in quintuplicate by adding an appropriate volume of fortification solution. Only compounds that showed a correlation coefficient (R2) higher than 0.93 were kept in the method.

The accuracy (bias and precision) was calculated for all the 12 fortification levels injected in the chromatographic systems in quintuplicate. The bias is expressed as the percentage of the theoretical level of fortification. As recommended in the guidelines, only compounds with recoveries between 70% and 120% were kept in the method. However, due to their importance for biomonitoring certain exceptions were admitted, including some compounds with recovery percentages below or above these limits, but which were highly reproducible. Precision (repeatability and reproducibility) is expressed in terms of relative standard deviation (RSD) of the different replicates. For the reproducibility of the method, only 5 levels of fortification (0.1, 0.5, 1, 5, and 20 ng/ml) were prepared in triplicate on three different days, within a period of 2 weeks. Therefore, the RSDs were calculated from 9 values. Only those compounds in which the RSD values were less than 20% remained in the method. In Table 1, we show the data of these 3 parameters only for the five levels of fortification mentioned above, although the rest also met the specified criteria.

The LOQ of this methodology was calculated over five runs of fortified blank matrix samples of three different sources (chicken, goat, and a mixture of both), as recommended (Scientific Working Group for Forensic, 2013). The lowest non-zero calibrator approximation was employed to calculate de LOQs. This means that the lowest point of the calibration curve that complied identity, bias and precision criteria was set as the LOQ for a given compound. All compounds with LOQ> 5 ng/ml were eliminated from the method since these levels are not considered adequate for biomonitoring studies. The calculated LOQs are shown in Table 1.

The influence of the matrix components on the performance of the method was evaluated by applying the extraction method to a sufficient quantity of blank whole blood to produce a blank matrix extract, which was subsequently fortified at three levels for the mixture of 360 chemicals (0.2, 2, and 20 ng/ml), and quantified against a calibration curve prepared in the solvent (1% FA-acetonitrile). The data corresponding to these experiments are shown in Fig. 1.

Application of the methodology to a series of blood samples of wild birds

The validated methodology was applied to a series of 148 real samples, composed of 36 samples from barn owls (Tyto alba) and 112 samples from common kestrels (Falco tinnunculus). These raptors were chosen as representative species of nocturnal and diurnal raptors and were sampled in the context of a project aimed to verify the penetration of anticoagulant rodenticides into the trophic chain of these species. Nest boxes located in the provinces of Palencia, Salamanca, Burgos, Segovia, Valladolid, and Zamora (Castilla-León, Spain) were sampled after a campaign with rodenticides against a common vole (Microtus arvalis) plague. All samples were collected after obtaining the corresponding permits and following the animal welfare protocols during the sampling [7]. The obtained data are shown in Tables 2 and 3 (barn owls) and Tables 3 and 4 (common kestrels).

Declaration of Competing Interest

The authors declare that they have no known competing financial interests or personal relationships which have, or could be perceived to have, influenced the work reported in this article.

Acknowledgments

Acknowledgments

This research was supported by the University of Las Palmas de Gran Canaria via a doctoral grant to the first author Cristian Rial-Berriel (ULPGC-012-2016), and also supported by the Spanish Ministry of Education, Culture and Sports via a doctoral grant to the co-first author Andrea Acosta-Dacal (FPU16-01888). The authors would like to thank people from Tafira Wildlife Rehabilitation Center (Gran Canaria, Spain), specially Dr. Alejandro Suárez Pérez. We also thank Mrs. Ana Macías Montes and Dr. Luis Alberto Henríquez Hernández for their assistance in the laboratory of Toxicology of University of Las Palmas de Gran Canaria.

Ethics statement

All samples were collected after obtaining the corresponding permits and following the animal welfare protocols during the sampling [7].

Footnotes

Supplementary material associated with this article can be found, in the online version, at doi:10.1016/j.dib.2020.105878.

Appendix. Supplementary materials

mmc1.xlsx (113.8KB, xlsx)
mmc2.xlsx (33.5KB, xlsx)
mmc3.xlsx (33.1KB, xlsx)

References

  • 1.EC SANTE/12682/2019. Guidance Document on Analytical Quality Control and Method Validation Procedures for Pesticide Residues and Analysis in Food and Feed. 2019.
  • 2.SWGTOX Scientific Working Group for Forensic Toxicology (SWGTOX) standard practices for method validation in forensic toxicology. J. Anal. Toxicol. 2013;37(7):452–474. doi: 10.1093/jat/bkt054. [DOI] [PubMed] [Google Scholar]
  • 3.Rial-Berriel C. Micro QuEChERS-based method for the simultaneous biomonitoring in whole blood of 360 toxicologically relevant pollutants for wildlife. Sci. Total Environ. 2020;736 doi: 10.1016/j.scitotenv.2020.139444. [DOI] [PubMed] [Google Scholar]
  • 4.Luzardo O.P. Multi-residue method for the determination of 57 persistent organic pollutants in human milk and colostrum using a QuEChERS-based extraction procedure. Anal. Bioanal. Chem. 2013;405(29):9523–9536. doi: 10.1007/s00216-013-7377-0. [DOI] [PubMed] [Google Scholar]
  • 5.Luzardo O.P., Ruiz-Suárez N, Valerón PF. Methodology for the identification of 117 pesticides commonly involved in the poisoning of wildlife using GC-MS-MS and LC-MS-MS. J. Anal. Toxicol. 2014;38(3):155–163. doi: 10.1093/jat/bku009. [DOI] [PubMed] [Google Scholar]
  • 6.Luzardo O.P. Validated analytical methodology for the simultaneous determination of a wide range of pesticides in human blood using GC-MS/MS and LC-ESI/MS/MS and its application in two poisoning cases. Sci. Justice. 2015;55(5):307–315. doi: 10.1016/j.scijus.2015.04.007. [DOI] [PubMed] [Google Scholar]
  • 7.Espin S. Tracking pan-continental trends in environmental contamination using sentinel raptors-what types of samples should we use? Ecotoxicology. 2016;25(4):777–801. doi: 10.1007/s10646-016-1636-8. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

mmc1.xlsx (113.8KB, xlsx)
mmc2.xlsx (33.5KB, xlsx)
mmc3.xlsx (33.1KB, xlsx)

Articles from Data in Brief are provided here courtesy of Elsevier

RESOURCES